Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hmx3
|
ENSMUSG00000040148.5 | H6 homeobox 3 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr7_131542413_131542581 | Hmx3 | 370 | 0.806457 | -0.70 | 2.7e-09 | Click! |
chr7_131542134_131542285 | Hmx3 | 658 | 0.608285 | -0.43 | 1.1e-03 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr5_23850355_23851323 | 14.40 |
2700038G22Rik |
RIKEN cDNA 2700038G22 gene |
238 |
0.81 |
chr17_47909349_47909983 | 12.73 |
Gm15556 |
predicted gene 15556 |
12712 |
0.13 |
chr11_87368253_87368600 | 11.46 |
Ppm1e |
protein phosphatase 1E (PP2C domain containing) |
9403 |
0.12 |
chr5_33542035_33542598 | 11.11 |
Fam53a |
family with sequence similarity 53, member A |
86596 |
0.05 |
chr7_144808296_144808485 | 8.87 |
Gm9711 |
predicted gene 9711 |
16394 |
0.11 |
chr3_157732464_157732921 | 8.52 |
Gm33466 |
predicted gene, 33466 |
6284 |
0.26 |
chr18_42510920_42511513 | 8.23 |
Tcerg1 |
transcription elongation regulator 1 (CA150) |
271 |
0.91 |
chr5_8894851_8895125 | 7.92 |
Abcb4 |
ATP-binding cassette, sub-family B (MDR/TAP), member 4 |
1039 |
0.47 |
chr1_24612739_24612914 | 7.90 |
Gm10222 |
predicted gene 10222 |
126 |
0.59 |
chr9_64533581_64533938 | 7.57 |
Megf11 |
multiple EGF-like-domains 11 |
13140 |
0.25 |
chr7_103826611_103826778 | 7.51 |
Hbb-bs |
hemoglobin, beta adult s chain |
1031 |
0.23 |
chr4_116720426_116721428 | 7.51 |
Tesk2 |
testis-specific kinase 2 |
21 |
0.96 |
chr9_123678850_123679043 | 7.15 |
Slc6a20a |
solute carrier family 6 (neurotransmitter transporter), member 20A |
61 |
0.84 |
chr11_44512552_44512737 | 6.62 |
Rnf145 |
ring finger protein 145 |
6320 |
0.18 |
chr11_113014293_113014953 | 6.60 |
2610035D17Rik |
RIKEN cDNA 2610035D17 gene |
158454 |
0.04 |
chr4_83206835_83207691 | 6.58 |
Gm11185 |
predicted gene 11185 |
13275 |
0.19 |
chr13_23687309_23687625 | 6.57 |
H2bc4 |
H2B clustered histone 4 |
3268 |
0.06 |
chr7_103811151_103811488 | 6.42 |
Hbb-bt |
hemoglobin, beta adult t chain |
2677 |
0.09 |
chr10_60347132_60347318 | 6.32 |
Vsir |
V-set immunoregulatory receptor |
213 |
0.94 |
chr4_33923766_33925291 | 6.25 |
Cnr1 |
cannabinoid receptor 1 (brain) |
65 |
0.98 |
chr13_85126661_85127037 | 6.13 |
Gm4076 |
predicted gene 4076 |
665 |
0.69 |
chrX_136171094_136171425 | 6.13 |
Tceal8 |
transcription elongation factor A (SII)-like 8 |
942 |
0.41 |
chr5_102045771_102045931 | 6.02 |
Gm43787 |
predicted gene 43787 |
12218 |
0.18 |
chr2_156991546_156992589 | 5.99 |
Ndrg3 |
N-myc downstream regulated gene 3 |
11 |
0.96 |
chr16_95439185_95439529 | 5.98 |
Erg |
ETS transcription factor |
19888 |
0.24 |
chr10_54042474_54042667 | 5.98 |
Gm47917 |
predicted gene, 47917 |
21241 |
0.18 |
chr5_112001700_112002600 | 5.96 |
Gm42488 |
predicted gene 42488 |
57915 |
0.13 |
chr6_120604620_120604802 | 5.85 |
Gm44124 |
predicted gene, 44124 |
24535 |
0.13 |
chr1_185731219_185731388 | 5.82 |
Gm38093 |
predicted gene, 38093 |
13500 |
0.27 |
chr11_53480005_53480347 | 5.80 |
Gm9945 |
predicted gene 9945 |
10 |
0.57 |
chr14_48445875_48446199 | 5.77 |
Tmem260 |
transmembrane protein 260 |
87 |
0.96 |
chr2_173736867_173737587 | 5.76 |
Vapb |
vesicle-associated membrane protein, associated protein B and C |
284 |
0.88 |
chr7_64958733_64958884 | 5.75 |
Gm25249 |
predicted gene, 25249 |
2232 |
0.36 |
chr16_72734272_72734567 | 5.75 |
Robo1 |
roundabout guidance receptor 1 |
71215 |
0.14 |
chr1_24613351_24614205 | 5.71 |
Gm28437 |
predicted gene 28437 |
193 |
0.69 |
chr1_9783703_9783860 | 5.65 |
1700034P13Rik |
RIKEN cDNA 1700034P13 gene |
3 |
0.97 |
chr11_101057938_101058139 | 5.60 |
Naglu |
alpha-N-acetylglucosaminidase (Sanfilippo disease IIIB) |
11974 |
0.08 |
chr8_120724834_120725149 | 5.57 |
Gm18709 |
predicted gene, 18709 |
2272 |
0.22 |
chr4_80002679_80002838 | 5.46 |
Gm11407 |
predicted gene 11407 |
427 |
0.69 |
chr7_90059784_90060230 | 5.35 |
Gm44861 |
predicted gene 44861 |
17310 |
0.12 |
chr4_59292306_59292644 | 5.34 |
Susd1 |
sushi domain containing 1 |
23491 |
0.17 |
chr15_77822081_77822487 | 5.29 |
Myh9 |
myosin, heavy polypeptide 9, non-muscle |
9053 |
0.15 |
chr8_83600902_83601120 | 5.28 |
Gm18001 |
predicted gene, 18001 |
998 |
0.34 |
chr11_120948784_120949183 | 5.17 |
Slc16a3 |
solute carrier family 16 (monocarboxylic acid transporters), member 3 |
70 |
0.95 |
chr12_16731064_16731426 | 5.11 |
Greb1 |
gene regulated by estrogen in breast cancer protein |
8883 |
0.17 |
chr3_137941200_137941383 | 5.08 |
Dapp1 |
dual adaptor for phosphotyrosine and 3-phosphoinositides 1 |
13422 |
0.1 |
chr7_24859341_24859609 | 5.03 |
Gm18207 |
predicted gene, 18207 |
1471 |
0.21 |
chr6_146981244_146981874 | 5.02 |
Ppfibp1 |
PTPRF interacting protein, binding protein 1 (liprin beta 1) |
5076 |
0.15 |
chr2_103896151_103896680 | 4.99 |
Gm13876 |
predicted gene 13876 |
8091 |
0.12 |
chr12_40836913_40837491 | 4.99 |
Gm19441 |
predicted gene, 19441 |
38335 |
0.13 |
chr5_137684632_137685345 | 4.94 |
Agfg2 |
ArfGAP with FG repeats 2 |
262 |
0.81 |
chr10_29313536_29314035 | 4.84 |
Gm46218 |
predicted gene, 46218 |
40 |
0.6 |
chr13_37756543_37756694 | 4.76 |
Gm31600 |
predicted gene, 31600 |
5130 |
0.16 |
chr10_93648032_93648457 | 4.75 |
Ntn4 |
netrin 4 |
7195 |
0.13 |
chr11_5575195_5575383 | 4.67 |
Ankrd36 |
ankyrin repeat domain 36 |
1206 |
0.39 |
chr12_97888699_97889409 | 4.67 |
Gm35326 |
predicted gene, 35326 |
16534 |
0.23 |
chr9_65826224_65827697 | 4.66 |
Zfp609 |
zinc finger protein 609 |
604 |
0.65 |
chr17_71097289_71097502 | 4.66 |
Myom1 |
myomesin 1 |
10999 |
0.16 |
chr13_23697544_23698095 | 4.66 |
H4c3 |
H4 clustered histone 3 |
635 |
0.35 |
chr3_144198270_144199266 | 4.62 |
Gm43445 |
predicted gene 43445 |
494 |
0.79 |
chr2_69818805_69818994 | 4.61 |
Klhl23 |
kelch-like 23 |
3045 |
0.15 |
chr17_79939191_79939342 | 4.61 |
Gm6552 |
predicted gene 6552 |
4694 |
0.2 |
chr6_102556596_102556901 | 4.61 |
Cntn3 |
contactin 3 |
16353 |
0.28 |
chr2_133430840_133431021 | 4.60 |
A430048G15Rik |
RIKEN cDNA A430048G15 gene |
1165 |
0.55 |
chr15_83344016_83344590 | 4.49 |
Arfgap3 |
ADP-ribosylation factor GTPase activating protein 3 |
5871 |
0.16 |
chr13_114831448_114831862 | 4.47 |
Mocs2 |
molybdenum cofactor synthesis 2 |
12750 |
0.24 |
chr3_14879873_14880124 | 4.42 |
Car2 |
carbonic anhydrase 2 |
6275 |
0.2 |
chr11_85843373_85844045 | 4.41 |
Gm11444 |
predicted gene 11444 |
6624 |
0.13 |
chr11_115833007_115833489 | 4.29 |
Llgl2 |
LLGL2 scribble cell polarity complex component |
677 |
0.52 |
chr6_116349806_116349968 | 4.23 |
Marchf8 |
membrane associated ring-CH-type finger 8 |
498 |
0.7 |
chr6_32472063_32472344 | 4.21 |
Plxna4os2 |
plexin A4, opposite strand 2 |
21033 |
0.22 |
chr14_57753296_57753601 | 4.19 |
Lats2 |
large tumor suppressor 2 |
4940 |
0.14 |
chr18_6516413_6517044 | 4.18 |
Epc1 |
enhancer of polycomb homolog 1 |
620 |
0.7 |
chr8_109436759_109437295 | 4.18 |
Gm23163 |
predicted gene, 23163 |
11283 |
0.22 |
chr13_90939682_90939863 | 4.18 |
Rps23 |
ribosomal protein S23 |
15587 |
0.21 |
chr16_91565033_91565184 | 4.17 |
Ifngr2 |
interferon gamma receptor 2 |
3785 |
0.13 |
chr16_91292688_91293239 | 4.17 |
Olig1 |
oligodendrocyte transcription factor 1 |
23191 |
0.11 |
chr1_97633201_97633352 | 4.15 |
AC099860.1 |
proline rich protein BstNI subfamily 4 (PRB4), pseudogene |
27555 |
0.17 |
chr4_118143697_118143848 | 4.14 |
Kdm4a |
lysine (K)-specific demethylase 4A |
2987 |
0.21 |
chr6_124683793_124684111 | 4.13 |
Lpcat3 |
lysophosphatidylcholine acyltransferase 3 |
17467 |
0.06 |
chr18_74741125_74741578 | 4.13 |
Myo5b |
myosin VB |
7586 |
0.18 |
chrX_93831605_93832731 | 4.13 |
Pdk3 |
pyruvate dehydrogenase kinase, isoenzyme 3 |
33 |
0.98 |
chr4_136143104_136143903 | 4.10 |
Id3 |
inhibitor of DNA binding 3 |
6 |
0.97 |
chr16_34047647_34047931 | 4.09 |
Kalrn |
kalirin, RhoGEF kinase |
31295 |
0.17 |
chr12_79674954_79675872 | 4.08 |
9430078K24Rik |
RIKEN cDNA 9430078K24 gene |
249320 |
0.02 |
chr15_31224173_31224992 | 4.08 |
Dap |
death-associated protein |
22 |
0.98 |
chr4_72328718_72329040 | 4.07 |
C630043F03Rik |
RIKEN cDNA C630043F03 gene |
127531 |
0.05 |
chr11_68767765_68767916 | 4.07 |
Myh10 |
myosin, heavy polypeptide 10, non-muscle |
15592 |
0.19 |
chr1_185470117_185470268 | 4.06 |
Gm2061 |
predicted gene 2061 |
14624 |
0.12 |
chr8_122463460_122463636 | 4.06 |
Snai3 |
snail family zinc finger 3 |
2815 |
0.11 |
chr2_167628701_167629206 | 4.04 |
Ube2v1 |
ubiquitin-conjugating enzyme E2 variant 1 |
3014 |
0.15 |
chr16_72699156_72700074 | 4.03 |
Robo1 |
roundabout guidance receptor 1 |
36411 |
0.24 |
chr8_85365297_85365473 | 3.99 |
Mylk3 |
myosin light chain kinase 3 |
38 |
0.97 |
chr12_12509201_12509901 | 3.98 |
4921511I17Rik |
RIKEN cDNA 4921511I17 gene |
116936 |
0.06 |
chr3_86108923_86109074 | 3.96 |
Gm25188 |
predicted gene, 25188 |
8464 |
0.11 |
chr15_62934546_62934877 | 3.95 |
Tsg101-ps |
tumor susceptibility gene 101, pseudogene |
45937 |
0.19 |
chr7_103909517_103909932 | 3.95 |
Olfr65 |
olfactory receptor 65 |
3382 |
0.08 |
chr11_116506385_116506879 | 3.93 |
Rpl36-ps1 |
ribosomal protein L36, pseudogene 1 |
2096 |
0.17 |
chr18_42262448_42262930 | 3.90 |
Lars |
leucyl-tRNA synthetase |
495 |
0.7 |
chr4_154582703_154583275 | 3.90 |
Gm13134 |
predicted gene 13134 |
18208 |
0.15 |
chr5_75961860_75962030 | 3.89 |
Kdr |
kinase insert domain protein receptor |
16513 |
0.17 |
chr14_26593397_26593744 | 3.89 |
Dennd6a |
DENN/MADD domain containing 6A |
11101 |
0.12 |
chr15_58592269_58592967 | 3.87 |
Fer1l6 |
fer-1-like 6 (C. elegans) |
45887 |
0.16 |
chr13_60743715_60744413 | 3.84 |
Dapk1 |
death associated protein kinase 1 |
9932 |
0.16 |
chr10_91181110_91181295 | 3.84 |
Tmpo |
thymopoietin |
85 |
0.97 |
chr3_95624529_95625035 | 3.82 |
Ensa |
endosulfine alpha |
211 |
0.86 |
chr13_11837934_11838197 | 3.81 |
Ryr2 |
ryanodine receptor 2, cardiac |
8411 |
0.23 |
chr17_29438725_29438928 | 3.80 |
Gm36486 |
predicted gene, 36486 |
1378 |
0.3 |
chr1_133434301_133434787 | 3.80 |
Sox13 |
SRY (sex determining region Y)-box 13 |
10167 |
0.19 |
chr13_95671451_95671789 | 3.79 |
Iqgap2 |
IQ motif containing GTPase activating protein 2 |
101 |
0.96 |
chr10_127311969_127312120 | 3.77 |
Mars1 |
methionine-tRNA synthetase 1 |
258 |
0.74 |
chr1_165765728_165766269 | 3.77 |
Creg1 |
cellular repressor of E1A-stimulated genes 1 |
2252 |
0.15 |
chr8_23167432_23167862 | 3.76 |
Gpat4 |
glycerol-3-phosphate acyltransferase 4 |
12580 |
0.1 |
chr10_116909346_116909505 | 3.76 |
Rab3ip |
RAB3A interacting protein |
10508 |
0.14 |
chr12_31950221_31950427 | 3.75 |
Hbp1 |
high mobility group box transcription factor 1 |
90 |
0.97 |
chr4_138065957_138066120 | 3.75 |
Eif4g3 |
eukaryotic translation initiation factor 4 gamma, 3 |
61286 |
0.1 |
chr11_98741567_98742727 | 3.74 |
Thra |
thyroid hormone receptor alpha |
11 |
0.95 |
chr6_33440622_33440907 | 3.74 |
Gm43168 |
predicted gene 43168 |
7756 |
0.27 |
chr7_144786081_144786237 | 3.73 |
Gm34964 |
predicted gene, 34964 |
5649 |
0.12 |
chr1_80428054_80428206 | 3.73 |
1700016L21Rik |
RIKEN cDNA 1700016L21 gene |
17802 |
0.15 |
chr5_74649196_74649374 | 3.73 |
Lnx1 |
ligand of numb-protein X 1 |
25764 |
0.15 |
chr13_104285003_104285221 | 3.73 |
Adamts6 |
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 6 |
2723 |
0.29 |
chr2_146577252_146577409 | 3.71 |
4933406D12Rik |
RIKEN cDNA 4933406D12 gene |
34399 |
0.2 |
chr4_12087867_12088383 | 3.71 |
Tmem67 |
transmembrane protein 67 |
118 |
0.93 |
chr7_123420015_123420410 | 3.69 |
Lcmt1 |
leucine carboxyl methyltransferase 1 |
2069 |
0.31 |
chr9_109875170_109875628 | 3.69 |
Cdc25a |
cell division cycle 25A |
180 |
0.91 |
chr2_52602270_52602578 | 3.68 |
Bloc1s2-ps |
biogenesis of lysosomal organelles complex-1, subunit 2, pseudogene |
17330 |
0.2 |
chr11_48855844_48857180 | 3.67 |
Gm16170 |
predicted gene 16170 |
3019 |
0.13 |
chr4_111635618_111636040 | 3.67 |
Agbl4 |
ATP/GTP binding protein-like 4 |
69104 |
0.11 |
chr2_32074486_32074637 | 3.66 |
Fam78a |
family with sequence similarity 78, member A |
4791 |
0.12 |
chr7_110916018_110916286 | 3.66 |
Mrvi1 |
MRV integration site 1 |
7551 |
0.17 |
chr9_108347370_108348421 | 3.65 |
Usp4 |
ubiquitin specific peptidase 4 (proto-oncogene) |
2 |
0.94 |
chr2_181496359_181496647 | 3.64 |
Tpd52l2 |
tumor protein D52-like 2 |
639 |
0.54 |
chr10_127508848_127510720 | 3.62 |
Stac3 |
SH3 and cysteine rich domain 3 |
2559 |
0.15 |
chr11_59885300_59885570 | 3.59 |
Gm12714 |
predicted gene 12714 |
12939 |
0.11 |
chr7_103808332_103808505 | 3.59 |
Hbb-bt |
hemoglobin, beta adult t chain |
5578 |
0.07 |
chr2_11853678_11853844 | 3.59 |
Gm34768 |
predicted gene, 34768 |
46321 |
0.13 |
chr7_45062619_45062939 | 3.58 |
Prrg2 |
proline-rich Gla (G-carboxyglutamic acid) polypeptide 2 |
102 |
0.66 |
chr10_105423144_105423438 | 3.54 |
Gm48203 |
predicted gene, 48203 |
29005 |
0.15 |
chr7_122020256_122021011 | 3.53 |
Gga2 |
golgi associated, gamma adaptin ear containing, ARF binding protein 2 |
534 |
0.7 |
chr7_28179836_28180482 | 3.53 |
Dyrk1b |
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1b |
107 |
0.93 |
chr15_25498410_25498830 | 3.52 |
Gm48957 |
predicted gene, 48957 |
40131 |
0.14 |
chr12_17770579_17770851 | 3.51 |
Hpcal1 |
hippocalcin-like 1 |
42489 |
0.14 |
chr8_33905789_33906327 | 3.51 |
Rbpms |
RNA binding protein gene with multiple splicing |
14294 |
0.16 |
chr4_101247491_101247691 | 3.50 |
Jak1 |
Janus kinase 1 |
17632 |
0.12 |
chr10_62327543_62328005 | 3.50 |
Hk1 |
hexokinase 1 |
7 |
0.97 |
chr1_85580713_85581405 | 3.49 |
Sp110 |
Sp110 nuclear body protein |
3219 |
0.13 |
chr7_65337972_65338245 | 3.48 |
Tjp1 |
tight junction protein 1 |
4689 |
0.24 |
chr17_35743072_35743233 | 3.48 |
Gm20443 |
predicted gene 20443 |
3346 |
0.11 |
chr6_120579566_120580923 | 3.47 |
Gm44124 |
predicted gene, 44124 |
68 |
0.96 |
chrX_9303552_9303716 | 3.46 |
Gm25481 |
predicted gene, 25481 |
14185 |
0.11 |
chr9_67235542_67235843 | 3.46 |
Mir190a |
microRNA 190a |
1034 |
0.55 |
chr2_131180295_131180465 | 3.45 |
Cenpb |
centromere protein B |
313 |
0.79 |
chr7_103877549_103877803 | 3.45 |
Olfr66 |
olfactory receptor 66 |
4565 |
0.07 |
chr13_14033395_14033670 | 3.45 |
Tbce |
tubulin-specific chaperone E |
6047 |
0.13 |
chr9_107971775_107971975 | 3.40 |
Uba7 |
ubiquitin-like modifier activating enzyme 7 |
3630 |
0.07 |
chr7_103814646_103814854 | 3.39 |
Hbb-bt |
hemoglobin, beta adult t chain |
754 |
0.35 |
chr7_25268029_25268452 | 3.39 |
Cic |
capicua transcriptional repressor |
147 |
0.9 |
chr1_39068024_39068183 | 3.38 |
Gm37821 |
predicted gene, 37821 |
10466 |
0.18 |
chr10_94688801_94689397 | 3.38 |
Cep83 |
centrosomal protein 83 |
381 |
0.56 |
chr11_117838543_117838973 | 3.38 |
Afmid |
arylformamidase |
6485 |
0.09 |
chr6_88821087_88821238 | 3.37 |
Mgll |
monoglyceride lipase |
1968 |
0.2 |
chr5_116023179_116023683 | 3.35 |
Prkab1 |
protein kinase, AMP-activated, beta 1 non-catalytic subunit |
925 |
0.45 |
chr17_84933085_84933242 | 3.34 |
Ppm1b |
protein phosphatase 1B, magnesium dependent, beta isoform |
23578 |
0.14 |
chr4_49546983_49547143 | 3.34 |
Aldob |
aldolase B, fructose-bisphosphate |
2483 |
0.21 |
chr10_78395785_78396875 | 3.32 |
Gm10146 |
predicted gene 10146 |
3010 |
0.11 |
chr5_23782972_23783928 | 3.31 |
Pus7 |
pseudouridylate synthase 7 |
103 |
0.93 |
chr10_59578107_59578404 | 3.29 |
Gm10322 |
predicted gene 10322 |
37808 |
0.15 |
chr6_34884510_34884686 | 3.28 |
Cyren |
cell cycle regulator of NHEJ |
6538 |
0.13 |
chr10_58371567_58371922 | 3.25 |
Lims1 |
LIM and senescent cell antigen-like domains 1 |
290 |
0.91 |
chr5_140645168_140645484 | 3.25 |
Ttyh3 |
tweety family member 3 |
3671 |
0.17 |
chr5_91200347_91200638 | 3.25 |
Gm23092 |
predicted gene, 23092 |
17512 |
0.2 |
chr19_5727451_5728139 | 3.25 |
Gm16538 |
predicted gene 16538 |
589 |
0.4 |
chr19_25347892_25348043 | 3.23 |
Gm34432 |
predicted gene, 34432 |
764 |
0.72 |
chr13_16023381_16024064 | 3.23 |
B230303A05Rik |
RIKEN cDNA B230303A05 gene |
299 |
0.86 |
chr16_91464461_91465455 | 3.22 |
A930006K02Rik |
RIKEN cDNA A930006K02 gene |
67 |
0.46 |
chr13_21782342_21782545 | 3.22 |
H3c11 |
H3 clustered histone 11 |
927 |
0.2 |
chr11_60176319_60177391 | 3.21 |
Rai1 |
retinoic acid induced 1 |
976 |
0.44 |
chr1_21660699_21661216 | 3.19 |
Gm7658 |
predicted gene 7658 |
147901 |
0.04 |
chr8_114882578_114882764 | 3.18 |
Gm22556 |
predicted gene, 22556 |
170242 |
0.03 |
chr7_102272522_102272823 | 3.18 |
Stim1 |
stromal interaction molecule 1 |
4345 |
0.15 |
chr9_50594626_50595065 | 3.17 |
Sdhd |
succinate dehydrogenase complex, subunit D, integral membrane protein |
8967 |
0.1 |
chr11_95309554_95309931 | 3.17 |
Kat7 |
K(lysine) acetyltransferase 7 |
140 |
0.87 |
chr2_158143494_158143664 | 3.14 |
Tgm2 |
transglutaminase 2, C polypeptide |
2787 |
0.22 |
chr7_141558685_141558858 | 3.14 |
Ap2a2 |
adaptor-related protein complex 2, alpha 2 subunit |
3402 |
0.14 |
chr14_59533354_59533505 | 3.14 |
Cab39l |
calcium binding protein 39-like |
54613 |
0.1 |
chr4_33498644_33498874 | 3.11 |
Gm11935 |
predicted gene 11935 |
45870 |
0.15 |
chr12_104814298_104814722 | 3.11 |
Clmn |
calmin |
33639 |
0.15 |
chr18_64646756_64647037 | 3.10 |
Atp8b1 |
ATPase, class I, type 8B, member 1 |
13911 |
0.14 |
chr15_36164587_36165183 | 3.09 |
Fbxo43 |
F-box protein 43 |
1 |
0.96 |
chr11_30166598_30166865 | 3.06 |
Sptbn1 |
spectrin beta, non-erythrocytic 1 |
31526 |
0.19 |
chr2_135700777_135701082 | 3.04 |
Gm14211 |
predicted gene 14211 |
7775 |
0.2 |
chr3_116507521_116507706 | 3.04 |
Rtca |
RNA 3'-terminal phosphate cyclase |
411 |
0.73 |
chr7_75498820_75499028 | 3.03 |
Gm44695 |
predicted gene 44695 |
14063 |
0.17 |
chr11_47939918_47940069 | 3.03 |
Gm23039 |
predicted gene, 23039 |
27448 |
0.23 |
chr5_120579891_120580190 | 3.03 |
Tpcn1 |
two pore channel 1 |
8554 |
0.09 |
chr11_95793003_95793275 | 3.03 |
Phospho1 |
phosphatase, orphan 1 |
31360 |
0.09 |
chr13_37460302_37460827 | 3.03 |
Gm29458 |
predicted gene 29458 |
7356 |
0.1 |
chr10_121614055_121614206 | 3.02 |
Xpot |
exportin, tRNA (nuclear export receptor for tRNAs) |
537 |
0.7 |
chr17_48272064_48272554 | 3.01 |
Treml4 |
triggering receptor expressed on myeloid cells-like 4 |
130 |
0.94 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 6.0 | GO:0035524 | proline transmembrane transport(GO:0035524) |
2.0 | 6.0 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
1.7 | 5.1 | GO:0008050 | female courtship behavior(GO:0008050) |
1.7 | 5.0 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
1.6 | 6.2 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
1.4 | 4.1 | GO:0048769 | sarcomerogenesis(GO:0048769) |
1.3 | 6.4 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
1.2 | 3.7 | GO:0000087 | mitotic M phase(GO:0000087) |
1.2 | 4.9 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
1.0 | 4.1 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
1.0 | 4.0 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
1.0 | 2.9 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.9 | 2.8 | GO:2000836 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.9 | 4.4 | GO:0070627 | ferrous iron import(GO:0070627) |
0.8 | 2.5 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.8 | 0.8 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.8 | 3.9 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.8 | 3.8 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.8 | 2.3 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.8 | 2.3 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.7 | 1.4 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.7 | 2.1 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.7 | 5.9 | GO:0046606 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.6 | 7.8 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.6 | 2.6 | GO:0051031 | tRNA transport(GO:0051031) |
0.6 | 3.0 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.6 | 5.3 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.6 | 2.9 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.6 | 1.7 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.6 | 1.7 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.6 | 1.7 | GO:2000909 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.5 | 1.6 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.5 | 4.7 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.5 | 2.1 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.5 | 2.6 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.5 | 2.1 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.5 | 1.5 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.5 | 2.0 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.5 | 2.0 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.5 | 2.0 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.5 | 3.0 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.5 | 1.9 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.5 | 1.4 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.5 | 3.8 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.5 | 1.8 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.5 | 3.7 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.4 | 1.3 | GO:0042938 | dipeptide transport(GO:0042938) |
0.4 | 1.3 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.4 | 0.9 | GO:0032439 | endosome localization(GO:0032439) |
0.4 | 1.3 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.4 | 3.5 | GO:0097286 | iron ion import(GO:0097286) |
0.4 | 2.6 | GO:0015671 | oxygen transport(GO:0015671) |
0.4 | 1.7 | GO:0008228 | opsonization(GO:0008228) |
0.4 | 1.3 | GO:0061623 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
0.4 | 1.3 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.4 | 0.9 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.4 | 1.3 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.4 | 2.5 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.4 | 1.7 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.4 | 1.2 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.4 | 1.2 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.4 | 1.2 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.4 | 2.9 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.4 | 3.7 | GO:0070269 | pyroptosis(GO:0070269) |
0.4 | 2.0 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.4 | 2.0 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.4 | 1.2 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
0.4 | 1.2 | GO:0014858 | positive regulation of skeletal muscle cell proliferation(GO:0014858) |
0.4 | 0.4 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.4 | 1.2 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.4 | 1.2 | GO:0061010 | gall bladder development(GO:0061010) |
0.4 | 1.6 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.4 | 3.1 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.4 | 1.5 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.4 | 0.4 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
0.4 | 3.0 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.4 | 0.7 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.4 | 1.1 | GO:0046439 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.4 | 1.1 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.4 | 1.1 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.4 | 1.1 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.4 | 1.4 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.4 | 3.2 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.4 | 1.1 | GO:0002584 | negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.4 | 1.4 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
0.3 | 1.0 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.3 | 1.4 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.3 | 1.0 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.3 | 2.7 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.3 | 1.4 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.3 | 2.0 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.3 | 4.8 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.3 | 1.0 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.3 | 1.0 | GO:1902730 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.3 | 1.7 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.3 | 1.0 | GO:0033668 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.3 | 1.7 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.3 | 2.3 | GO:0060613 | fat pad development(GO:0060613) |
0.3 | 0.7 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.3 | 1.3 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.3 | 1.3 | GO:0009838 | abscission(GO:0009838) |
0.3 | 1.6 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.3 | 2.9 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.3 | 1.9 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.3 | 0.9 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.3 | 0.3 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.3 | 1.2 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
0.3 | 0.6 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.3 | 1.2 | GO:0070295 | renal water absorption(GO:0070295) |
0.3 | 0.9 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.3 | 0.6 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
0.3 | 4.6 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.3 | 1.2 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.3 | 0.6 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.3 | 0.6 | GO:0021827 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) |
0.3 | 0.9 | GO:0050904 | diapedesis(GO:0050904) |
0.3 | 0.6 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.3 | 0.6 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
0.3 | 0.9 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.3 | 1.2 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.3 | 1.5 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
0.3 | 2.0 | GO:0006573 | valine metabolic process(GO:0006573) |
0.3 | 1.7 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.3 | 0.9 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.3 | 0.3 | GO:0019661 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.3 | 0.9 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.3 | 0.6 | GO:0006868 | glutamine transport(GO:0006868) |
0.3 | 1.1 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.3 | 2.0 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.3 | 0.8 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.3 | 1.4 | GO:0031052 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.3 | 0.3 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.3 | 0.6 | GO:0060596 | mammary placode formation(GO:0060596) |
0.3 | 1.1 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.3 | 0.3 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.3 | 1.1 | GO:0003383 | apical constriction(GO:0003383) |
0.3 | 0.8 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.3 | 0.3 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.3 | 0.5 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.3 | 0.8 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.3 | 0.8 | GO:0046533 | negative regulation of photoreceptor cell differentiation(GO:0046533) |
0.3 | 0.3 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.3 | 0.5 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.3 | 0.8 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
0.3 | 1.6 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.3 | 0.8 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
0.3 | 2.4 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
0.3 | 0.5 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.3 | 0.5 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.3 | 3.4 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.3 | 1.0 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.3 | 2.1 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.3 | 0.5 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.3 | 1.3 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.3 | 1.8 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.3 | 0.5 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.2 | 0.2 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.2 | 0.7 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.2 | 2.0 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.2 | 1.0 | GO:0070836 | caveola assembly(GO:0070836) |
0.2 | 1.7 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.2 | 0.7 | GO:0033121 | regulation of purine nucleotide catabolic process(GO:0033121) |
0.2 | 1.2 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
0.2 | 0.7 | GO:0019086 | late viral transcription(GO:0019086) |
0.2 | 1.7 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.2 | 1.2 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.2 | 1.2 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.2 | 0.7 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.2 | 0.9 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.2 | 1.2 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.2 | 0.7 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.2 | 0.9 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.2 | 0.5 | GO:0036216 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.2 | 1.4 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.2 | 0.2 | GO:0090259 | regulation of retinal ganglion cell axon guidance(GO:0090259) |
0.2 | 1.4 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.2 | 1.1 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.2 | 1.4 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.2 | 0.2 | GO:0003176 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
0.2 | 0.9 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.2 | 0.5 | GO:0046136 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
0.2 | 0.7 | GO:0035973 | aggrephagy(GO:0035973) |
0.2 | 1.6 | GO:0006569 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.2 | 2.2 | GO:0030575 | nuclear body organization(GO:0030575) |
0.2 | 0.9 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.2 | 0.9 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.2 | 4.4 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.2 | 0.2 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.2 | 1.1 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.2 | 1.5 | GO:0034204 | lipid translocation(GO:0034204) |
0.2 | 0.9 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.2 | 2.6 | GO:0042407 | cristae formation(GO:0042407) |
0.2 | 4.6 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.2 | 0.2 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.2 | 1.7 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.2 | 0.9 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.2 | 0.2 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.2 | 0.4 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
0.2 | 0.2 | GO:1904180 | negative regulation of membrane depolarization(GO:1904180) |
0.2 | 2.8 | GO:1903392 | negative regulation of adherens junction organization(GO:1903392) |
0.2 | 0.8 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.2 | 0.6 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
0.2 | 0.6 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.2 | 1.7 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.2 | 0.4 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.2 | 1.0 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.2 | 0.6 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.2 | 0.2 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.2 | 0.4 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.2 | 1.0 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.2 | 1.2 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.2 | 2.5 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.2 | 0.6 | GO:0021590 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
0.2 | 0.8 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.2 | 1.0 | GO:1900038 | negative regulation of cellular response to hypoxia(GO:1900038) |
0.2 | 3.5 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.2 | 0.4 | GO:0042762 | regulation of sulfur metabolic process(GO:0042762) |
0.2 | 0.4 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.2 | 0.6 | GO:0098787 | mRNA cleavage involved in mRNA processing(GO:0098787) |
0.2 | 0.8 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.2 | 1.0 | GO:0097242 | beta-amyloid clearance(GO:0097242) |
0.2 | 1.0 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) |
0.2 | 1.0 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.2 | 0.6 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
0.2 | 1.6 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.2 | 1.0 | GO:0030812 | negative regulation of nucleotide catabolic process(GO:0030812) |
0.2 | 1.6 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
0.2 | 3.1 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.2 | 0.2 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.2 | 0.4 | GO:0051029 | rRNA transport(GO:0051029) |
0.2 | 0.6 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.2 | 1.0 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.2 | 0.2 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.2 | 0.4 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.2 | 0.6 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.2 | 0.2 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
0.2 | 1.5 | GO:0051601 | exocyst localization(GO:0051601) |
0.2 | 0.6 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.2 | 0.9 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.2 | 0.8 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.2 | 0.2 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.2 | 1.9 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.2 | 0.9 | GO:2001182 | regulation of interleukin-12 secretion(GO:2001182) |
0.2 | 1.3 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.2 | 1.8 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.2 | 2.0 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.2 | 1.1 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.2 | 0.6 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.2 | 0.6 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.2 | 1.5 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.2 | 0.9 | GO:0018904 | ether metabolic process(GO:0018904) |
0.2 | 0.5 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.2 | 1.1 | GO:0032328 | alanine transport(GO:0032328) |
0.2 | 6.3 | GO:0007045 | cell-substrate adherens junction assembly(GO:0007045) focal adhesion assembly(GO:0048041) |
0.2 | 0.7 | GO:2001168 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.2 | 0.4 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.2 | 0.2 | GO:0061511 | centriole elongation(GO:0061511) |
0.2 | 0.2 | GO:1905214 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
0.2 | 0.2 | GO:2000619 | negative regulation of histone H4-K16 acetylation(GO:2000619) |
0.2 | 1.1 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.2 | 1.6 | GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
0.2 | 0.4 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.2 | 0.4 | GO:0002432 | granuloma formation(GO:0002432) |
0.2 | 0.5 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.2 | 1.4 | GO:0046415 | urate metabolic process(GO:0046415) |
0.2 | 0.2 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.2 | 1.0 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.2 | 0.5 | GO:0048478 | replication fork protection(GO:0048478) |
0.2 | 0.3 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.2 | 0.9 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.2 | 0.7 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.2 | 0.2 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.2 | 0.7 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.2 | 0.3 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.2 | 0.8 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.2 | 1.9 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.2 | 0.7 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.2 | 5.4 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.2 | 0.2 | GO:0010535 | positive regulation of activation of JAK2 kinase activity(GO:0010535) |
0.2 | 0.7 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.2 | 1.0 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.2 | 0.8 | GO:0009249 | protein lipoylation(GO:0009249) |
0.2 | 1.0 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.2 | 0.2 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.2 | 0.3 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.2 | 1.6 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.2 | 3.1 | GO:0060612 | adipose tissue development(GO:0060612) |
0.2 | 0.5 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.2 | 0.5 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.2 | 3.1 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.2 | 1.0 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.2 | 0.6 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.2 | 1.3 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.2 | 0.2 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.2 | 0.6 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.2 | 1.7 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
0.2 | 0.5 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
0.2 | 0.3 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.2 | 2.3 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.2 | 0.3 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
0.2 | 0.3 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.2 | 1.2 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.2 | 0.3 | GO:0021764 | amygdala development(GO:0021764) |
0.2 | 0.2 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
0.2 | 0.5 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.2 | 0.6 | GO:0060556 | vitamin D biosynthetic process(GO:0042368) regulation of vitamin D biosynthetic process(GO:0060556) |
0.2 | 0.5 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
0.2 | 0.8 | GO:0015705 | iodide transport(GO:0015705) |
0.2 | 2.3 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.1 | 0.9 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.7 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 0.4 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.1 | 0.6 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.1 | 0.3 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.1 | 1.5 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.1 | 0.6 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.1 | 0.1 | GO:0015817 | histidine transport(GO:0015817) |
0.1 | 0.3 | GO:0009176 | pyrimidine deoxyribonucleoside monophosphate metabolic process(GO:0009176) |
0.1 | 0.3 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.1 | 0.4 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.1 | 2.9 | GO:0006301 | postreplication repair(GO:0006301) |
0.1 | 0.4 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.1 | 0.3 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.1 | 0.4 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.1 | 6.0 | GO:0043038 | amino acid activation(GO:0043038) |
0.1 | 0.4 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.1 | 0.4 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.1 | 0.3 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.1 | 0.4 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.1 | 0.6 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.1 | 0.6 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.1 | 0.7 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.1 | 0.7 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.1 | 0.3 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.1 | 0.3 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.1 | 0.1 | GO:0043366 | beta selection(GO:0043366) |
0.1 | 0.1 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.1 | 0.8 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.1 | 0.6 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.1 | 2.2 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.1 | 0.1 | GO:0002278 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
0.1 | 4.9 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.1 | 1.9 | GO:1903861 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.1 | 0.4 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.1 | 0.3 | GO:2000104 | negative regulation of DNA-dependent DNA replication(GO:2000104) |
0.1 | 0.5 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
0.1 | 0.7 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.1 | 0.5 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.1 | 0.1 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 0.5 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.1 | 0.1 | GO:0009080 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.1 | 0.4 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.1 | 0.8 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
0.1 | 3.5 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.1 | 0.7 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) |
0.1 | 1.3 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.1 | 0.3 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.1 | 0.5 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.1 | 0.7 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 2.0 | GO:0071800 | podosome assembly(GO:0071800) |
0.1 | 0.5 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.1 | 1.1 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 0.1 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.1 | 0.4 | GO:0034214 | protein hexamerization(GO:0034214) |
0.1 | 0.7 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.1 | 1.0 | GO:0010388 | cullin deneddylation(GO:0010388) |
0.1 | 0.4 | GO:1902268 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) negative regulation of polyamine transmembrane transport(GO:1902268) |
0.1 | 0.8 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 0.3 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.1 | 0.1 | GO:2000978 | negative regulation of forebrain neuron differentiation(GO:2000978) |
0.1 | 3.0 | GO:0046460 | neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
0.1 | 0.3 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.1 | 0.1 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.1 | 0.4 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
0.1 | 0.4 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.1 | 0.1 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.1 | 0.4 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.1 | 0.3 | GO:2000391 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.1 | 0.4 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.1 | 0.3 | GO:0046931 | pore complex assembly(GO:0046931) |
0.1 | 0.5 | GO:0018214 | protein carboxylation(GO:0018214) |
0.1 | 0.5 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.1 | 0.1 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
0.1 | 0.6 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 0.1 | GO:0044854 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) |
0.1 | 0.6 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.1 | 1.0 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.1 | 0.2 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.1 | 0.4 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.1 | 0.2 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.1 | 1.2 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.1 | 0.4 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.1 | 0.1 | GO:2000977 | regulation of forebrain neuron differentiation(GO:2000977) |
0.1 | 1.8 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.1 | 1.6 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 0.6 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.1 | 0.2 | GO:2001267 | regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001267) |
0.1 | 0.4 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.1 | 0.4 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.1 | 0.6 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.1 | 0.1 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.1 | 0.7 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.1 | 0.5 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 1.9 | GO:0030488 | tRNA methylation(GO:0030488) |
0.1 | 2.4 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 0.2 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.1 | 0.4 | GO:0015888 | thiamine transport(GO:0015888) |
0.1 | 3.1 | GO:0035825 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.1 | 0.2 | GO:0006848 | pyruvate transport(GO:0006848) |
0.1 | 0.7 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 0.1 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.1 | 0.6 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.1 | 1.5 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.1 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.1 | 0.4 | GO:0015682 | ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
0.1 | 0.1 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.1 | 0.2 | GO:0042078 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.1 | 0.8 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
0.1 | 0.3 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.1 | 0.7 | GO:1901660 | calcium ion export(GO:1901660) |
0.1 | 1.0 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.1 | 0.9 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 0.2 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.1 | 0.3 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 0.3 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.1 | 0.6 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.1 | 0.1 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.1 | 0.6 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.1 | 0.3 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.1 | 1.7 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.1 | 0.3 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.1 | 2.7 | GO:0010761 | fibroblast migration(GO:0010761) |
0.1 | 0.2 | GO:0009804 | coumarin metabolic process(GO:0009804) |
0.1 | 1.3 | GO:0030826 | regulation of cGMP biosynthetic process(GO:0030826) |
0.1 | 1.3 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.1 | 0.3 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.1 | 0.3 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.1 | 0.6 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.1 | 0.6 | GO:0009113 | purine nucleobase biosynthetic process(GO:0009113) |
0.1 | 0.3 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.2 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
0.1 | 0.2 | GO:0060056 | mammary gland involution(GO:0060056) |
0.1 | 0.8 | GO:0097341 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.1 | 0.4 | GO:0001842 | neural fold formation(GO:0001842) |
0.1 | 0.1 | GO:0072553 | terminal button organization(GO:0072553) |
0.1 | 0.1 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.1 | 0.3 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.1 | 0.3 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 0.3 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.1 | 1.4 | GO:0031639 | plasminogen activation(GO:0031639) |
0.1 | 0.5 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.1 | 0.4 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.1 | 0.6 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.1 | 1.8 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.1 | 3.9 | GO:0006406 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.1 | 0.2 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.1 | 0.2 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.1 | 2.1 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.1 | 0.1 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
0.1 | 0.3 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 0.2 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.1 | 0.2 | GO:1904304 | regulation of gastro-intestinal system smooth muscle contraction(GO:1904304) |
0.1 | 0.3 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.1 | 0.4 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.1 | 0.3 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.1 | 0.2 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
0.1 | 1.0 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.1 | 0.5 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.1 | 0.8 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 0.3 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.1 | 1.3 | GO:1904030 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.1 | 0.3 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.1 | 0.4 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.1 | 0.3 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.1 | 0.7 | GO:0090169 | regulation of spindle assembly(GO:0090169) regulation of mitotic spindle assembly(GO:1901673) |
0.1 | 0.3 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.1 | 0.1 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.1 | 0.4 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.1 | 0.1 | GO:0048308 | organelle inheritance(GO:0048308) |
0.1 | 0.3 | GO:0007296 | vitellogenesis(GO:0007296) |
0.1 | 0.1 | GO:2000410 | thymocyte migration(GO:0072679) regulation of thymocyte migration(GO:2000410) positive regulation of thymocyte migration(GO:2000412) |
0.1 | 0.1 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.1 | 0.3 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.1 | 2.7 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.1 | 0.1 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.1 | 0.1 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.1 | 0.8 | GO:0045624 | positive regulation of T-helper cell differentiation(GO:0045624) |
0.1 | 0.6 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.1 | 0.1 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
0.1 | 0.2 | GO:1902473 | regulation of protein localization to synapse(GO:1902473) |
0.1 | 0.6 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 0.5 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.1 | 0.3 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.1 | 0.4 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.1 | 0.8 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.1 | 0.4 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.1 | 0.1 | GO:0002424 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.1 | 0.7 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.1 | 1.0 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.1 | 0.9 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
0.1 | 0.3 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 0.3 | GO:2000121 | regulation of removal of superoxide radicals(GO:2000121) |
0.1 | 0.7 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.1 | 0.1 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.1 | 0.1 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.1 | 0.1 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.1 | 0.1 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.1 | 0.1 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.1 | 0.8 | GO:0036035 | osteoclast development(GO:0036035) |
0.1 | 0.5 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 1.9 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.1 | 0.4 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.1 | 1.1 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.1 | 0.4 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.1 | 0.8 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.1 | 0.2 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.1 | 0.3 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.1 | 0.1 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.1 | 0.1 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
0.1 | 0.6 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.1 | 0.2 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.1 | 0.2 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.1 | 0.5 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.1 | 1.1 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 0.1 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.1 | 0.3 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.1 | 1.3 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.1 | 0.8 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.1 | 2.5 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.1 | 0.2 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.1 | 1.1 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.1 | 0.3 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.1 | 0.5 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.1 | 0.2 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.1 | 0.2 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.1 | 0.1 | GO:0010165 | response to X-ray(GO:0010165) |
0.1 | 0.5 | GO:0035437 | maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.1 | 1.2 | GO:0006828 | manganese ion transport(GO:0006828) |
0.1 | 0.2 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.1 | 0.2 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.1 | 0.8 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 | 0.5 | GO:0042637 | catagen(GO:0042637) |
0.1 | 0.2 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.1 | 0.8 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.1 | 0.1 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.1 | 0.3 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.3 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.1 | 0.2 | GO:0043144 | snoRNA processing(GO:0043144) |
0.1 | 0.2 | GO:1904754 | positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
0.1 | 2.2 | GO:0006953 | acute-phase response(GO:0006953) |
0.1 | 0.3 | GO:0032485 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
0.1 | 1.8 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.1 | 1.1 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.1 | 0.2 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.1 | 0.3 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 0.4 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.1 | 0.1 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.1 | 0.1 | GO:0097049 | motor neuron apoptotic process(GO:0097049) |
0.1 | 0.9 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.1 | 1.0 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.1 | 0.3 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.1 | 0.1 | GO:0035483 | gastric motility(GO:0035482) gastric emptying(GO:0035483) |
0.1 | 1.1 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.2 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.1 | 0.2 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.1 | 0.5 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.3 | GO:0031943 | regulation of glucocorticoid metabolic process(GO:0031943) negative regulation of glucocorticoid metabolic process(GO:0031944) regulation of glucocorticoid biosynthetic process(GO:0031946) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
0.1 | 0.1 | GO:0015867 | ATP transport(GO:0015867) |
0.1 | 0.4 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.1 | 0.3 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
0.1 | 0.1 | GO:0071374 | response to parathyroid hormone(GO:0071107) cellular response to parathyroid hormone stimulus(GO:0071374) |
0.1 | 0.5 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.1 | 0.3 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.1 | 0.1 | GO:0002676 | regulation of chronic inflammatory response(GO:0002676) |
0.1 | 0.5 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.1 | 0.3 | GO:0031657 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.1 | 0.1 | GO:0019054 | modulation by virus of host process(GO:0019054) |
0.1 | 0.3 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.1 | 0.6 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 0.3 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
0.1 | 0.9 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.1 | 0.2 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.1 | 0.2 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.1 | 0.1 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.1 | 0.1 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.1 | 0.4 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.1 | 0.2 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.1 | 0.3 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.1 | 0.7 | GO:0051452 | intracellular pH reduction(GO:0051452) |
0.1 | 0.3 | GO:0006568 | tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
0.1 | 0.1 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.1 | 0.3 | GO:0086013 | membrane repolarization during cardiac muscle cell action potential(GO:0086013) |
0.1 | 0.3 | GO:0060674 | placenta blood vessel development(GO:0060674) |
0.1 | 0.2 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.1 | 0.7 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
0.1 | 0.2 | GO:0045064 | T-helper 2 cell differentiation(GO:0045064) |
0.1 | 2.7 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.1 | 0.2 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.2 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.1 | 0.7 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.1 | 1.3 | GO:0007094 | mitotic spindle assembly checkpoint(GO:0007094) spindle assembly checkpoint(GO:0071173) |
0.1 | 0.2 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.1 | 0.2 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.1 | 0.2 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.1 | 0.4 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 0.2 | GO:2000392 | regulation of lamellipodium morphogenesis(GO:2000392) |
0.1 | 0.4 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.1 | 0.2 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.1 | 0.2 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.1 | 0.2 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.2 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.1 | 0.2 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.1 | 0.2 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.1 | 0.3 | GO:0008355 | olfactory learning(GO:0008355) |
0.1 | 0.1 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
0.1 | 0.4 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.1 | 0.8 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.1 | 0.5 | GO:0007398 | ectoderm development(GO:0007398) |
0.1 | 0.2 | GO:1902808 | positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.1 | 0.4 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.1 | 0.3 | GO:0042730 | fibrinolysis(GO:0042730) |
0.1 | 0.1 | GO:0018158 | protein oxidation(GO:0018158) |
0.1 | 1.0 | GO:0032402 | melanosome transport(GO:0032402) |
0.1 | 0.1 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.1 | 0.1 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.1 | 0.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.1 | 0.1 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.1 | 0.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 0.3 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 0.1 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.1 | 0.4 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.1 | 0.1 | GO:0046490 | isopentenyl diphosphate metabolic process(GO:0046490) |
0.1 | 0.5 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
0.1 | 0.9 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.1 | 0.3 | GO:0009648 | photoperiodism(GO:0009648) |
0.1 | 0.8 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.1 | 0.1 | GO:0009650 | UV protection(GO:0009650) |
0.1 | 0.2 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.1 | 0.1 | GO:0015886 | heme transport(GO:0015886) |
0.1 | 0.3 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.1 | 0.2 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.1 | 0.9 | GO:0008272 | sulfate transport(GO:0008272) |
0.1 | 0.4 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.1 | 0.1 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.1 | 0.1 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.1 | 0.1 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.1 | 0.2 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.1 | 1.1 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 0.4 | GO:0046326 | positive regulation of glucose import(GO:0046326) |
0.1 | 0.1 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.1 | 0.1 | GO:0010694 | regulation of alkaline phosphatase activity(GO:0010692) positive regulation of alkaline phosphatase activity(GO:0010694) |
0.1 | 0.1 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
0.1 | 0.7 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 1.6 | GO:0070527 | platelet aggregation(GO:0070527) |
0.1 | 0.1 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.1 | 1.1 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.1 | 0.1 | GO:0010586 | miRNA metabolic process(GO:0010586) |
0.1 | 0.3 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.1 | 0.3 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.1 | 0.5 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.1 | 0.3 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 0.7 | GO:0046461 | neutral lipid catabolic process(GO:0046461) acylglycerol catabolic process(GO:0046464) |
0.1 | 1.5 | GO:0015914 | phospholipid transport(GO:0015914) |
0.1 | 0.1 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.1 | 1.5 | GO:0048821 | erythrocyte development(GO:0048821) |
0.1 | 0.3 | GO:0044819 | mitotic G1 DNA damage checkpoint(GO:0031571) mitotic G1/S transition checkpoint(GO:0044819) |
0.1 | 0.1 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.1 | 1.0 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.1 | 0.1 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.1 | 0.1 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.1 | 2.1 | GO:0007569 | cell aging(GO:0007569) |
0.1 | 0.1 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.1 | 0.1 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.1 | 0.7 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.1 | 0.5 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 1.9 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.1 | 0.1 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.1 | 1.2 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.1 | 0.3 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 1.3 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.1 | 2.6 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.1 | 0.1 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.1 | 0.2 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.1 | 0.1 | GO:0032513 | negative regulation of protein phosphatase type 2B activity(GO:0032513) |
0.1 | 0.3 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.1 | 1.6 | GO:1901998 | toxin transport(GO:1901998) |
0.1 | 0.3 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.1 | 0.2 | GO:1901797 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
0.1 | 0.1 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 0.1 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.1 | 0.4 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.1 | 0.6 | GO:0030449 | regulation of complement activation(GO:0030449) |
0.1 | 0.7 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.1 | 0.9 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.1 | 0.1 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.1 | 0.1 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.1 | 0.1 | GO:0044351 | macropinocytosis(GO:0044351) |
0.1 | 0.3 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.1 | 0.1 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.1 | 0.4 | GO:0071435 | potassium ion export(GO:0071435) |
0.1 | 0.2 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.1 | 0.1 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) phenylpropanoid catabolic process(GO:0046271) |
0.1 | 0.4 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.1 | 0.8 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.1 | 0.5 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.1 | 0.1 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.1 | 0.1 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.1 | 0.3 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.1 | 0.3 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.1 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.1 | 0.1 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.1 | 0.1 | GO:0002586 | regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
0.1 | 2.3 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.1 | 0.1 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.1 | 0.1 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.1 | 0.4 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.1 | 0.3 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.1 | 0.2 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.1 | 0.1 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
0.1 | 0.2 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.1 | 0.2 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.1 | 0.1 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 0.1 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.1 | 0.2 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.1 | 0.2 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.1 | 0.6 | GO:0046514 | ceramide catabolic process(GO:0046514) |
0.1 | 0.1 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.1 | 0.2 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.1 | 0.1 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.1 | 0.7 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 0.1 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.1 | 0.2 | GO:0015819 | lysine transport(GO:0015819) |
0.1 | 0.1 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.1 | 0.8 | GO:0010842 | retina layer formation(GO:0010842) |
0.1 | 0.5 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.1 | 0.2 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.1 | 0.2 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) |
0.1 | 0.2 | GO:0072396 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.1 | 0.3 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.1 | 1.7 | GO:0045727 | positive regulation of translation(GO:0045727) |
0.1 | 0.2 | GO:0040033 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.1 | 1.4 | GO:0006284 | base-excision repair(GO:0006284) |
0.1 | 0.3 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.1 | 0.1 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.1 | 0.3 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 0.5 | GO:0007614 | short-term memory(GO:0007614) |
0.1 | 0.1 | GO:0003228 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.1 | 0.1 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
0.1 | 0.2 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.1 | 0.2 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 0.2 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.1 | 0.1 | GO:1902369 | negative regulation of RNA catabolic process(GO:1902369) |
0.1 | 0.1 | GO:0045341 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.1 | 1.2 | GO:0048286 | lung alveolus development(GO:0048286) |
0.1 | 0.7 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.1 | 0.6 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.1 | 0.2 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.1 | 0.1 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.1 | 0.2 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.1 | 1.0 | GO:0035065 | regulation of histone acetylation(GO:0035065) |
0.1 | 0.1 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.1 | 0.2 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.1 | 0.1 | GO:0051972 | regulation of telomerase activity(GO:0051972) |
0.1 | 0.2 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.1 | 0.1 | GO:2000726 | negative regulation of cardiac muscle cell differentiation(GO:2000726) |
0.1 | 0.2 | GO:0032261 | purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
0.1 | 0.1 | GO:0060534 | trachea cartilage development(GO:0060534) trachea cartilage morphogenesis(GO:0060535) |
0.1 | 0.1 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.1 | 0.3 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 1.3 | GO:0019319 | hexose biosynthetic process(GO:0019319) |
0.1 | 0.5 | GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage(GO:0008630) |
0.1 | 0.1 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.1 | 0.2 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.1 | 0.8 | GO:0032355 | response to estradiol(GO:0032355) |
0.1 | 0.2 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.1 | 0.2 | GO:0044546 | NLRP3 inflammasome complex assembly(GO:0044546) positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.1 | 0.1 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.1 | 0.2 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.1 | 0.1 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.1 | 0.2 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.1 | 0.1 | GO:1901970 | positive regulation of mitotic sister chromatid separation(GO:1901970) |
0.1 | 0.1 | GO:0033574 | response to testosterone(GO:0033574) |
0.1 | 0.2 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.1 | 0.2 | GO:2000637 | positive regulation of gene silencing by miRNA(GO:2000637) |
0.1 | 1.6 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 0.8 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.1 | 0.6 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.1 | 0.1 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.1 | 1.7 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.1 | 0.1 | GO:0032741 | positive regulation of interleukin-18 production(GO:0032741) |
0.1 | 0.8 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.2 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.1 | 0.1 | GO:0051352 | negative regulation of ligase activity(GO:0051352) |
0.1 | 0.7 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 0.5 | GO:0007099 | centriole replication(GO:0007099) centriole assembly(GO:0098534) |
0.1 | 0.2 | GO:0009188 | ribonucleoside diphosphate biosynthetic process(GO:0009188) |
0.1 | 0.1 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.1 | 0.1 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.1 | 0.1 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.1 | 0.7 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
0.1 | 1.9 | GO:0006721 | terpenoid metabolic process(GO:0006721) |
0.1 | 1.3 | GO:0007127 | meiosis I(GO:0007127) |
0.1 | 0.4 | GO:0060711 | labyrinthine layer development(GO:0060711) |
0.1 | 0.5 | GO:0000154 | rRNA modification(GO:0000154) |
0.1 | 0.1 | GO:0045625 | regulation of T-helper 1 cell differentiation(GO:0045625) |
0.1 | 0.1 | GO:0072008 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
0.1 | 0.4 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.1 | 0.1 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.1 | 0.2 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.1 | 4.0 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.1 | 0.1 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 0.2 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.1 | 0.1 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
0.1 | 0.1 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.1 | 0.2 | GO:0090207 | regulation of triglyceride metabolic process(GO:0090207) |
0.1 | 0.5 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.1 | 0.1 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.1 | 0.1 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.1 | 0.5 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.1 | 0.1 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 0.3 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.1 | 0.1 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.1 | 0.3 | GO:0006165 | nucleoside diphosphate phosphorylation(GO:0006165) |
0.0 | 1.5 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.0 | 0.0 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.0 | 0.2 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.0 | 0.9 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.2 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.0 | 0.1 | GO:0002803 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antibacterial peptide production(GO:0002803) |
0.0 | 0.2 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.0 | 0.1 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
0.0 | 0.1 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.0 | 0.2 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.0 | 0.2 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.0 | 0.9 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 0.1 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.0 | 0.3 | GO:0097421 | liver regeneration(GO:0097421) |
0.0 | 0.1 | GO:2000641 | regulation of early endosome to late endosome transport(GO:2000641) |
0.0 | 0.0 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
0.0 | 0.1 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.0 | 0.2 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.0 | 0.1 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.0 | 0.0 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.0 | 0.1 | GO:1904478 | regulation of intestinal absorption(GO:1904478) |
0.0 | 0.1 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.0 | 0.1 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.0 | 0.3 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.0 | 2.6 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.0 | 0.2 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.0 | 0.1 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.0 | 0.1 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.0 | 0.4 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.0 | 0.3 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.0 | 0.0 | GO:0071223 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
0.0 | 0.1 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.0 | 0.0 | GO:0002866 | positive regulation of acute inflammatory response to antigenic stimulus(GO:0002866) |
0.0 | 0.3 | GO:1903573 | negative regulation of response to endoplasmic reticulum stress(GO:1903573) |
0.0 | 0.0 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.0 | 0.0 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.0 | 0.4 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 0.1 | GO:0070268 | cornification(GO:0070268) |
0.0 | 0.1 | GO:0080009 | mRNA methylation(GO:0080009) |
0.0 | 0.0 | GO:0051571 | positive regulation of histone H3-K4 methylation(GO:0051571) |
0.0 | 0.0 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.0 | 0.7 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.4 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.0 | 0.1 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.0 | 0.2 | GO:0042749 | regulation of circadian sleep/wake cycle(GO:0042749) |
0.0 | 0.1 | GO:0036005 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
0.0 | 0.1 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.0 | 0.2 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.0 | 0.2 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.0 | 0.1 | GO:0043400 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) positive regulation of cortisol secretion(GO:0051464) |
0.0 | 0.0 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.0 | 0.2 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.0 | 0.3 | GO:0006896 | Golgi to vacuole transport(GO:0006896) |
0.0 | 0.1 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.0 | 0.1 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.0 | 0.0 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.0 | 0.1 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.0 | 0.1 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.0 | 0.0 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
0.0 | 0.0 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.0 | 1.3 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
0.0 | 0.6 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.0 | 0.3 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.0 | 0.0 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
0.0 | 1.0 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.0 | 0.1 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.0 | 0.9 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.0 | 0.2 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.0 | 0.1 | GO:0031958 | corticosteroid receptor signaling pathway(GO:0031958) |
0.0 | 0.1 | GO:0014888 | striated muscle adaptation(GO:0014888) |
0.0 | 0.2 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.2 | GO:1901409 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.0 | 0.2 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.0 | 0.2 | GO:0045834 | positive regulation of lipid metabolic process(GO:0045834) |
0.0 | 0.1 | GO:0009642 | response to light intensity(GO:0009642) |
0.0 | 0.0 | GO:0010455 | positive regulation of cell fate commitment(GO:0010455) |
0.0 | 1.0 | GO:0006096 | glycolytic process(GO:0006096) |
0.0 | 0.2 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.0 | 0.5 | GO:0008214 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.0 | 0.1 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.0 | 0.3 | GO:0042670 | retinal cone cell differentiation(GO:0042670) |
0.0 | 0.1 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.0 | 0.1 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.0 | 0.4 | GO:0002347 | response to tumor cell(GO:0002347) |
0.0 | 0.1 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.0 | 0.2 | GO:0042711 | maternal behavior(GO:0042711) |
0.0 | 0.0 | GO:0061743 | motor learning(GO:0061743) |
0.0 | 0.0 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.0 | 0.1 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.0 | 0.1 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.0 | 0.3 | GO:0036230 | granulocyte activation(GO:0036230) |
0.0 | 0.2 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.0 | 0.2 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.0 | 0.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.0 | 0.5 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
0.0 | 0.1 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.0 | 0.1 | GO:0006826 | iron ion transport(GO:0006826) |
0.0 | 0.0 | GO:1904031 | positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.0 | 0.0 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.0 | 0.2 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.0 | 0.1 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.0 | 0.0 | GO:0015865 | purine nucleotide transport(GO:0015865) purine ribonucleotide transport(GO:0015868) |
0.0 | 0.5 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.0 | 0.2 | GO:0032310 | prostaglandin secretion(GO:0032310) |
0.0 | 0.6 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.0 | 0.1 | GO:0016264 | gap junction assembly(GO:0016264) |
0.0 | 0.0 | GO:0045911 | positive regulation of DNA recombination(GO:0045911) |
0.0 | 1.3 | GO:0032526 | response to retinoic acid(GO:0032526) |
0.0 | 0.8 | GO:0022900 | electron transport chain(GO:0022900) |
0.0 | 0.1 | GO:0033685 | regulation of luteinizing hormone secretion(GO:0033684) negative regulation of luteinizing hormone secretion(GO:0033685) |
0.0 | 0.2 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.0 | 0.2 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.0 | 0.1 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.0 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.0 | 0.3 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 0.4 | GO:0010906 | regulation of glucose metabolic process(GO:0010906) |
0.0 | 0.2 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.0 | 0.2 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.0 | 0.3 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.0 | 0.1 | GO:0070989 | oxidative demethylation(GO:0070989) |
0.0 | 0.1 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.0 | 0.6 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.0 | 0.4 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.1 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.0 | 0.0 | GO:0071335 | hair follicle cell proliferation(GO:0071335) regulation of hair follicle cell proliferation(GO:0071336) |
0.0 | 0.2 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.0 | 0.2 | GO:0030168 | platelet activation(GO:0030168) |
0.0 | 0.1 | GO:0042255 | ribosome assembly(GO:0042255) |
0.0 | 0.1 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.0 | 0.0 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.0 | 0.0 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.0 | 0.3 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 0.2 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.0 | 0.0 | GO:0006116 | NADH oxidation(GO:0006116) |
0.0 | 0.1 | GO:0070572 | positive regulation of neuron projection regeneration(GO:0070572) |
0.0 | 4.1 | GO:0006631 | fatty acid metabolic process(GO:0006631) |
0.0 | 0.6 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
0.0 | 0.6 | GO:1904888 | cranial skeletal system development(GO:1904888) |
0.0 | 0.1 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.0 | 0.0 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.0 | 0.2 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.0 | 0.1 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.0 | 0.4 | GO:0045061 | thymic T cell selection(GO:0045061) |
0.0 | 0.4 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.0 | 0.1 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
0.0 | 0.0 | GO:0048291 | isotype switching to IgG isotypes(GO:0048291) regulation of isotype switching to IgG isotypes(GO:0048302) |
0.0 | 0.2 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.0 | 0.6 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
0.0 | 0.1 | GO:0030431 | sleep(GO:0030431) |
0.0 | 0.0 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.0 | 0.2 | GO:0045806 | negative regulation of endocytosis(GO:0045806) |
0.0 | 0.1 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.0 | 0.1 | GO:0051181 | cofactor transport(GO:0051181) |
0.0 | 0.2 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.0 | 0.0 | GO:0044650 | virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) receptor-mediated virion attachment to host cell(GO:0046813) |
0.0 | 0.0 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.0 | 0.5 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.0 | 0.1 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.0 | 0.2 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.0 | 0.1 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.0 | 0.1 | GO:0035425 | autocrine signaling(GO:0035425) |
0.0 | 0.1 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.0 | 0.1 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.0 | 0.0 | GO:0018377 | protein myristoylation(GO:0018377) |
0.0 | 0.1 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.0 | 0.1 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.0 | 0.9 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.0 | 0.2 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.0 | 0.1 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.1 | GO:0071467 | cellular response to pH(GO:0071467) |
0.0 | 0.1 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.0 | 0.5 | GO:0050891 | multicellular organismal water homeostasis(GO:0050891) |
0.0 | 0.4 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
0.0 | 0.1 | GO:1904415 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.0 | 0.5 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.0 | 0.1 | GO:0036315 | cellular response to sterol(GO:0036315) |
0.0 | 0.0 | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.0 | 0.1 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.0 | 0.1 | GO:0060290 | transdifferentiation(GO:0060290) |
0.0 | 0.1 | GO:0010955 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.0 | 0.3 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.0 | 0.2 | GO:0050892 | intestinal absorption(GO:0050892) |
0.0 | 0.1 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.0 | 0.0 | GO:0021903 | rostrocaudal neural tube patterning(GO:0021903) |
0.0 | 0.0 | GO:0033034 | positive regulation of myeloid cell apoptotic process(GO:0033034) |
0.0 | 0.0 | GO:0010159 | specification of organ position(GO:0010159) |
0.0 | 0.2 | GO:0045604 | regulation of epidermal cell differentiation(GO:0045604) |
0.0 | 0.5 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.0 | 1.3 | GO:0016573 | histone acetylation(GO:0016573) |
0.0 | 0.0 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.0 | 0.2 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.0 | 0.1 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.0 | 0.0 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.0 | 1.3 | GO:0008033 | tRNA processing(GO:0008033) |
0.0 | 0.0 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.0 | 0.1 | GO:0035590 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.0 | 0.1 | GO:0070849 | response to epidermal growth factor(GO:0070849) |
0.0 | 0.9 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.0 | 0.3 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.0 | 0.0 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.0 | 0.1 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.0 | 0.1 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.0 | 0.3 | GO:1902108 | regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902108) |
0.0 | 0.0 | GO:0034440 | lipid oxidation(GO:0034440) |
0.0 | 0.1 | GO:0006405 | RNA export from nucleus(GO:0006405) |
0.0 | 0.0 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.0 | 0.4 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.0 | 0.5 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 0.1 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.0 | 1.9 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.0 | 0.7 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.0 | 0.0 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.0 | 0.2 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.0 | 0.2 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.0 | 0.1 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.0 | 0.6 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.0 | 0.0 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.0 | 0.1 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
0.0 | 0.0 | GO:0060768 | regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) |
0.0 | 0.1 | GO:0050665 | hydrogen peroxide biosynthetic process(GO:0050665) |
0.0 | 0.1 | GO:1904037 | positive regulation of epithelial cell apoptotic process(GO:1904037) |
0.0 | 0.1 | GO:0046697 | decidualization(GO:0046697) |
0.0 | 0.1 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.0 | 0.1 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.0 | 0.1 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
0.0 | 0.1 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.0 | 0.1 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.1 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.0 | 0.1 | GO:0070986 | left/right axis specification(GO:0070986) |
0.0 | 0.4 | GO:0006213 | pyrimidine nucleoside metabolic process(GO:0006213) |
0.0 | 0.3 | GO:1900046 | regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
0.0 | 7.0 | GO:0006412 | translation(GO:0006412) |
0.0 | 0.1 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.0 | 0.2 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 0.1 | GO:0016556 | mRNA modification(GO:0016556) |
0.0 | 0.7 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.0 | 0.0 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.0 | 0.0 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.0 | 0.1 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.0 | 0.0 | GO:1901679 | nucleotide transmembrane transport(GO:1901679) |
0.0 | 0.1 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.0 | 0.2 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.0 | 0.3 | GO:0051923 | sulfation(GO:0051923) |
0.0 | 0.0 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.0 | 0.0 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.0 | 0.0 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.0 | 0.0 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.0 | 0.1 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
0.0 | 0.1 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.0 | 0.1 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.0 | 0.0 | GO:0010225 | response to UV-C(GO:0010225) |
0.0 | 0.1 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.0 | 0.1 | GO:0045851 | pH reduction(GO:0045851) |
0.0 | 0.2 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.0 | 0.1 | GO:1903580 | positive regulation of nucleoside metabolic process(GO:0045979) positive regulation of ATP metabolic process(GO:1903580) |
0.0 | 0.1 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.0 | 0.2 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.0 | 0.1 | GO:0009115 | xanthine catabolic process(GO:0009115) xanthine metabolic process(GO:0046110) |
0.0 | 0.1 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.0 | 0.1 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.0 | 0.2 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.0 | 0.1 | GO:0060539 | diaphragm development(GO:0060539) |
0.0 | 0.0 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.0 | 0.1 | GO:0006399 | tRNA metabolic process(GO:0006399) |
0.0 | 0.2 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.0 | 0.1 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.0 | 0.2 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.0 | 0.2 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.0 | 0.1 | GO:0042168 | heme metabolic process(GO:0042168) |
0.0 | 0.2 | GO:0006638 | neutral lipid metabolic process(GO:0006638) |
0.0 | 0.5 | GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0006919) |
0.0 | 0.5 | GO:0006672 | ceramide metabolic process(GO:0006672) |
0.0 | 0.2 | GO:0003299 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.0 | 0.2 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.0 | 0.8 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.0 | 0.1 | GO:0010840 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
0.0 | 0.0 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.0 | 0.4 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.0 | 0.0 | GO:0035561 | regulation of chromatin binding(GO:0035561) |
0.0 | 0.0 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.0 | 0.3 | GO:0032204 | regulation of telomere maintenance(GO:0032204) |
0.0 | 0.1 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.0 | 0.1 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.1 | GO:1904970 | brush border assembly(GO:1904970) |
0.0 | 0.1 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.0 | 0.1 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.0 | 0.0 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.0 | 0.0 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.0 | 0.0 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
0.0 | 0.0 | GO:0044784 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) metaphase/anaphase transition of cell cycle(GO:0044784) |
0.0 | 0.0 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.0 | 0.3 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.0 | 0.0 | GO:0071514 | genetic imprinting(GO:0071514) |
0.0 | 0.0 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.0 | 0.3 | GO:1903363 | negative regulation of cellular protein catabolic process(GO:1903363) |
0.0 | 0.4 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.0 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.0 | 0.0 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.0 | 0.0 | GO:0007135 | meiosis II(GO:0007135) |
0.0 | 0.0 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
0.0 | 0.0 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.0 | 0.1 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
0.0 | 0.1 | GO:0010447 | response to acidic pH(GO:0010447) |
0.0 | 0.4 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.0 | 0.1 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.0 | 0.3 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.0 | 1.3 | GO:0006310 | DNA recombination(GO:0006310) |
0.0 | 0.0 | GO:2001225 | regulation of chloride transport(GO:2001225) |
0.0 | 0.6 | GO:0051297 | centrosome organization(GO:0051297) |
0.0 | 0.0 | GO:0002254 | kinin cascade(GO:0002254) |
0.0 | 0.0 | GO:1903140 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.0 | 0.0 | GO:0060379 | cardiac muscle cell myoblast differentiation(GO:0060379) |
0.0 | 0.1 | GO:0014002 | astrocyte development(GO:0014002) |
0.0 | 0.0 | GO:0006560 | proline metabolic process(GO:0006560) |
0.0 | 0.1 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.0 | 0.0 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.0 | 0.0 | GO:0014866 | skeletal myofibril assembly(GO:0014866) |
0.0 | 0.0 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.0 | 0.0 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.0 | 0.0 | GO:0001555 | oocyte growth(GO:0001555) |
0.0 | 0.0 | GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) |
0.0 | 0.0 | GO:0072319 | vesicle uncoating(GO:0072319) |
0.0 | 0.1 | GO:0051875 | pigment granule localization(GO:0051875) |
0.0 | 3.8 | GO:0008380 | RNA splicing(GO:0008380) |
0.0 | 0.1 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.0 | 0.1 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.0 | 0.1 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.0 | 0.1 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
0.0 | 0.3 | GO:0043297 | apical junction assembly(GO:0043297) |
0.0 | 0.8 | GO:0033673 | negative regulation of kinase activity(GO:0033673) |
0.0 | 0.0 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.0 | 0.0 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.0 | 0.1 | GO:0060180 | female mating behavior(GO:0060180) |
0.0 | 0.0 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.0 | 0.4 | GO:0051058 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.0 | 0.2 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.0 | 0.1 | GO:0030261 | chromosome condensation(GO:0030261) |
0.0 | 0.0 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.0 | 0.1 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.0 | 0.0 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
0.0 | 0.0 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.0 | 0.1 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.0 | 0.0 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.0 | 0.0 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.0 | 0.0 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.0 | 0.0 | GO:0061045 | negative regulation of wound healing(GO:0061045) |
0.0 | 0.0 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.0 | 0.0 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.0 | 0.0 | GO:0030220 | platelet formation(GO:0030220) |
0.0 | 0.0 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.0 | 0.0 | GO:0032367 | intracellular cholesterol transport(GO:0032367) |
0.0 | 0.0 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.0 | 0.2 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.0 | 0.3 | GO:0042246 | tissue regeneration(GO:0042246) |
0.0 | 0.0 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.0 | 0.0 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.0 | 0.4 | GO:0050817 | coagulation(GO:0050817) |
0.0 | 0.0 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.0 | 0.2 | GO:0019079 | viral genome replication(GO:0019079) |
0.0 | 0.1 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.0 | 0.0 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.0 | 0.0 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.0 | 0.0 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.0 | 0.0 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.0 | 0.1 | GO:0018101 | protein citrullination(GO:0018101) |
0.0 | 0.1 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.0 | 0.1 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.0 | 0.7 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 0.1 | GO:0055088 | lipid homeostasis(GO:0055088) |
0.0 | 0.2 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.0 | 0.1 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.0 | 0.0 | GO:0032800 | receptor biosynthetic process(GO:0032800) |
0.0 | 0.1 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.0 | 0.1 | GO:0072525 | pyridine-containing compound biosynthetic process(GO:0072525) |
0.0 | 0.0 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.0 | 0.0 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.0 | 0.0 | GO:0070841 | inclusion body assembly(GO:0070841) |
0.0 | 0.0 | GO:0072537 | fibroblast activation(GO:0072537) |
0.0 | 0.0 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.0 | 0.0 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.0 | 0.0 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.0 | 0.1 | GO:0032891 | negative regulation of organic acid transport(GO:0032891) |
0.0 | 0.0 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.0 | 0.1 | GO:0015858 | nucleoside transport(GO:0015858) |
0.0 | 0.0 | GO:0046689 | response to mercury ion(GO:0046689) |
0.0 | 0.0 | GO:2000780 | negative regulation of double-strand break repair(GO:2000780) |
0.0 | 0.0 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.0 | 0.1 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
0.0 | 0.0 | GO:0033275 | actin-myosin filament sliding(GO:0033275) |
0.0 | 0.1 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.0 | 0.0 | GO:1903306 | negative regulation of regulated secretory pathway(GO:1903306) |
0.0 | 0.1 | GO:0055072 | iron ion homeostasis(GO:0055072) |
0.0 | 0.1 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.0 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.0 | 0.1 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.0 | 0.0 | GO:0002159 | desmosome assembly(GO:0002159) |
0.0 | 0.3 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.2 | GO:0009303 | rRNA transcription(GO:0009303) |
0.0 | 0.0 | GO:0090003 | regulation of establishment of protein localization to plasma membrane(GO:0090003) |
0.0 | 0.0 | GO:0051451 | myoblast migration(GO:0051451) |
0.0 | 0.1 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.1 | GO:0031929 | TOR signaling(GO:0031929) |
0.0 | 0.0 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.0 | 0.0 | GO:0019614 | catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
0.0 | 0.0 | GO:0042737 | drug catabolic process(GO:0042737) |
0.0 | 0.7 | GO:0006457 | protein folding(GO:0006457) |
0.0 | 0.1 | GO:0014850 | response to muscle activity(GO:0014850) |
0.0 | 0.0 | GO:0043043 | peptide biosynthetic process(GO:0043043) |
0.0 | 0.1 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.0 | 0.1 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.0 | 0.0 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.0 | 0.2 | GO:0052696 | flavonoid metabolic process(GO:0009812) flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
0.0 | 0.0 | GO:1901068 | guanosine-containing compound metabolic process(GO:1901068) |
0.0 | 0.2 | GO:0007520 | myoblast fusion(GO:0007520) |
0.0 | 0.0 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.0 | 0.0 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.0 | 1.1 | GO:0006260 | DNA replication(GO:0006260) |
0.0 | 0.1 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.0 | 0.1 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 0.0 | GO:1990403 | embryonic brain development(GO:1990403) |
0.0 | 0.0 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.0 | 0.0 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.0 | 0.0 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.0 | 1.3 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.0 | 0.1 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.0 | 0.1 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.0 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.0 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.0 | 0.0 | GO:0001993 | regulation of systemic arterial blood pressure by norepinephrine-epinephrine(GO:0001993) |
0.0 | 0.0 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.0 | 0.0 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
0.0 | 0.1 | GO:0006081 | cellular aldehyde metabolic process(GO:0006081) |
0.0 | 0.1 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.0 | 0.0 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.0 | 0.0 | GO:1903077 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.0 | 0.0 | GO:0021603 | cranial nerve formation(GO:0021603) |
0.0 | 0.0 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.0 | 0.0 | GO:0071711 | basement membrane organization(GO:0071711) |
0.0 | 0.1 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.0 | 0.0 | GO:0006907 | pinocytosis(GO:0006907) |
0.0 | 0.0 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.0 | 0.1 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.0 | 1.4 | GO:0006511 | ubiquitin-dependent protein catabolic process(GO:0006511) |
0.0 | 0.1 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.0 | 0.0 | GO:0097499 | protein localization to nonmotile primary cilium(GO:0097499) |
0.0 | 0.0 | GO:0048525 | negative regulation of viral process(GO:0048525) |
0.0 | 0.0 | GO:0070861 | regulation of protein exit from endoplasmic reticulum(GO:0070861) |
0.0 | 0.0 | GO:1903010 | regulation of bone development(GO:1903010) |
0.0 | 0.2 | GO:0030574 | collagen catabolic process(GO:0030574) multicellular organism catabolic process(GO:0044243) |
0.0 | 0.0 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.0 | 0.0 | GO:0030238 | male sex determination(GO:0030238) |
0.0 | 13.8 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.0 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.0 | 0.0 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.0 | 0.0 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.0 | 0.0 | GO:0045987 | positive regulation of smooth muscle contraction(GO:0045987) |
0.0 | 0.1 | GO:0007616 | long-term memory(GO:0007616) |
0.0 | 0.1 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.0 | 0.1 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.0 | 0.0 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.0 | 0.0 | GO:0043084 | penile erection(GO:0043084) |
0.0 | 0.0 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.0 | 0.0 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.0 | 0.0 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.0 | 0.0 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.0 | 0.0 | GO:0072599 | establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.0 | 0.0 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.0 | 0.0 | GO:0015825 | L-serine transport(GO:0015825) |
0.0 | 0.1 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.0 | 0.0 | GO:2000757 | negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.0 | 0.1 | GO:0097006 | regulation of plasma lipoprotein particle levels(GO:0097006) |
0.0 | 0.0 | GO:0060618 | nipple development(GO:0060618) |
0.0 | 0.0 | GO:0070255 | regulation of mucus secretion(GO:0070255) |
0.0 | 0.0 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.0 | 0.0 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.0 | 0.0 | GO:0045581 | negative regulation of T cell differentiation(GO:0045581) |
0.0 | 0.0 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.0 | 0.0 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 5.2 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.7 | 7.5 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.7 | 2.9 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.7 | 2.0 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.6 | 1.3 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.6 | 1.8 | GO:0097513 | myosin II filament(GO:0097513) |
0.6 | 1.7 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.6 | 3.3 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.5 | 1.1 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.5 | 1.5 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.5 | 2.4 | GO:0089701 | U2AF(GO:0089701) |
0.5 | 2.7 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.4 | 1.3 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.4 | 1.3 | GO:0097443 | sorting endosome(GO:0097443) |
0.4 | 1.7 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.4 | 2.1 | GO:0005683 | U7 snRNP(GO:0005683) |
0.4 | 1.2 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.4 | 2.4 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.3 | 1.7 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.3 | 1.7 | GO:0030870 | Mre11 complex(GO:0030870) |
0.3 | 1.0 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.3 | 1.0 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.3 | 1.0 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.3 | 1.3 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.3 | 2.2 | GO:0016272 | prefoldin complex(GO:0016272) |
0.3 | 1.8 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.3 | 1.8 | GO:0070820 | tertiary granule(GO:0070820) |
0.3 | 1.1 | GO:0033269 | internode region of axon(GO:0033269) |
0.3 | 3.0 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.3 | 0.8 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.3 | 1.3 | GO:0000235 | astral microtubule(GO:0000235) |
0.3 | 3.4 | GO:0036038 | MKS complex(GO:0036038) |
0.3 | 3.8 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.3 | 1.3 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.3 | 1.0 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.2 | 0.2 | GO:0030135 | coated vesicle(GO:0030135) |
0.2 | 3.6 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.2 | 0.7 | GO:0031523 | Myb complex(GO:0031523) |
0.2 | 1.2 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.2 | 0.9 | GO:0072487 | MSL complex(GO:0072487) |
0.2 | 5.1 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.2 | 6.7 | GO:0031941 | filamentous actin(GO:0031941) |
0.2 | 2.4 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.2 | 0.4 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.2 | 0.8 | GO:0070938 | contractile ring(GO:0070938) |
0.2 | 0.8 | GO:0097470 | ribbon synapse(GO:0097470) |
0.2 | 1.0 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.2 | 2.5 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.2 | 0.6 | GO:0016939 | kinesin II complex(GO:0016939) |
0.2 | 0.6 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.2 | 5.7 | GO:0031902 | late endosome membrane(GO:0031902) |
0.2 | 3.5 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.2 | 0.6 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.2 | 1.4 | GO:0090543 | Flemming body(GO:0090543) |
0.2 | 13.4 | GO:0016363 | nuclear matrix(GO:0016363) |
0.2 | 1.0 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.2 | 2.0 | GO:0035102 | PRC1 complex(GO:0035102) |
0.2 | 1.3 | GO:0042382 | paraspeckles(GO:0042382) |
0.2 | 1.5 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.2 | 0.5 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.2 | 0.5 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.2 | 0.4 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.2 | 4.2 | GO:0097228 | sperm principal piece(GO:0097228) |
0.2 | 1.2 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.2 | 7.7 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.2 | 0.2 | GO:0032010 | phagolysosome(GO:0032010) |
0.2 | 1.4 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.2 | 1.5 | GO:0005869 | dynactin complex(GO:0005869) |
0.2 | 0.5 | GO:0097413 | Lewy body(GO:0097413) |
0.2 | 1.5 | GO:0042581 | specific granule(GO:0042581) |
0.2 | 0.8 | GO:0005827 | polar microtubule(GO:0005827) |
0.2 | 0.8 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.2 | 5.8 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.2 | 0.2 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.2 | 0.6 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.2 | 0.8 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.2 | 0.2 | GO:0042585 | germinal vesicle(GO:0042585) |
0.2 | 0.3 | GO:0001739 | sex chromatin(GO:0001739) |
0.2 | 1.7 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.2 | 0.8 | GO:0005916 | fascia adherens(GO:0005916) |
0.2 | 0.5 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.2 | 2.2 | GO:0001891 | phagocytic cup(GO:0001891) |
0.2 | 0.5 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.2 | 1.9 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 0.6 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.2 | 1.2 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.2 | 4.0 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.2 | 3.8 | GO:0005876 | spindle microtubule(GO:0005876) |
0.2 | 1.4 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.2 | 0.3 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.2 | 0.8 | GO:0001940 | male pronucleus(GO:0001940) |
0.1 | 0.9 | GO:0045179 | apical cortex(GO:0045179) |
0.1 | 1.2 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.1 | 1.5 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.1 | 0.1 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.1 | 1.3 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.1 | 0.1 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.1 | 0.6 | GO:1990246 | uniplex complex(GO:1990246) |
0.1 | 0.4 | GO:0097427 | microtubule bundle(GO:0097427) |
0.1 | 0.6 | GO:0008091 | spectrin(GO:0008091) |
0.1 | 0.7 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 0.4 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.1 | 0.4 | GO:0097452 | GAIT complex(GO:0097452) |
0.1 | 0.7 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.1 | 0.4 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.1 | 0.4 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 0.6 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.1 | 0.1 | GO:0000322 | storage vacuole(GO:0000322) |
0.1 | 9.2 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.1 | 0.5 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.1 | 5.6 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 1.9 | GO:0005682 | U5 snRNP(GO:0005682) |
0.1 | 5.9 | GO:0005795 | Golgi stack(GO:0005795) |
0.1 | 0.4 | GO:0000346 | transcription export complex(GO:0000346) |
0.1 | 3.8 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 0.4 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 0.4 | GO:0055087 | Ski complex(GO:0055087) |
0.1 | 0.1 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.1 | 0.5 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 0.4 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 1.8 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.5 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 1.2 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 0.8 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.1 | 0.4 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.1 | 0.5 | GO:0030891 | VCB complex(GO:0030891) |
0.1 | 0.4 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.1 | 0.5 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.1 | 3.2 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 1.5 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 0.7 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.1 | 1.6 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 0.3 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 2.9 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 1.3 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.1 | 0.3 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 31.2 | GO:0005925 | focal adhesion(GO:0005925) |
0.1 | 0.3 | GO:0005745 | m-AAA complex(GO:0005745) |
0.1 | 0.4 | GO:0071953 | elastic fiber(GO:0071953) |
0.1 | 0.2 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.1 | 0.6 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.1 | 0.4 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.1 | 0.5 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.1 | 0.3 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.1 | 0.5 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.1 | 0.1 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.1 | 0.8 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.6 | GO:0098651 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.1 | 0.3 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.1 | 1.8 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 0.1 | GO:0005840 | ribosome(GO:0005840) |
0.1 | 0.1 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.1 | 0.1 | GO:1990423 | RZZ complex(GO:1990423) |
0.1 | 0.3 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.1 | 0.5 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.1 | 0.1 | GO:0030689 | Noc complex(GO:0030689) |
0.1 | 0.9 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 0.2 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.1 | 0.3 | GO:0097422 | tubular endosome(GO:0097422) |
0.1 | 0.7 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.1 | 3.7 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 0.3 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.1 | 0.4 | GO:0044194 | cytolytic granule(GO:0044194) |
0.1 | 0.4 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 2.2 | GO:0031672 | A band(GO:0031672) |
0.1 | 0.2 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.1 | 11.6 | GO:0000139 | Golgi membrane(GO:0000139) |
0.1 | 0.4 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.1 | 0.4 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.1 | 0.5 | GO:0035861 | site of double-strand break(GO:0035861) |
0.1 | 0.5 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 2.0 | GO:0000786 | nucleosome(GO:0000786) |
0.1 | 5.2 | GO:0005814 | centriole(GO:0005814) |
0.1 | 0.5 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.1 | 18.4 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.1 | 0.2 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 0.4 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.1 | 0.2 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 0.9 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 3.2 | GO:0045171 | intercellular bridge(GO:0045171) |
0.1 | 0.9 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.1 | 0.3 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 0.3 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.1 | 0.2 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.1 | 0.2 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.1 | 1.0 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 0.2 | GO:0000805 | X chromosome(GO:0000805) |
0.1 | 0.6 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.1 | 0.2 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.1 | 3.8 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 0.2 | GO:0035363 | histone locus body(GO:0035363) |
0.1 | 3.8 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 1.8 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 0.8 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
0.1 | 0.2 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.1 | 2.4 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.1 | 0.4 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 0.3 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 0.1 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 0.2 | GO:1990726 | U6 snRNP(GO:0005688) Lsm1-7-Pat1 complex(GO:1990726) |
0.1 | 1.4 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 0.8 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.1 | 0.1 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.1 | 1.7 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.1 | 3.4 | GO:0016605 | PML body(GO:0016605) |
0.1 | 0.7 | GO:0045178 | basal part of cell(GO:0045178) |
0.1 | 0.1 | GO:0005638 | lamin filament(GO:0005638) |
0.1 | 1.2 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 2.1 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 1.4 | GO:0015030 | Cajal body(GO:0015030) |
0.1 | 0.2 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.1 | 0.4 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 0.4 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.1 | 0.6 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 3.2 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.8 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.1 | 1.7 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 0.3 | GO:0031415 | NatA complex(GO:0031415) |
0.1 | 0.2 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 1.2 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 0.4 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 0.7 | GO:1902562 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.1 | 0.3 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.1 | 0.5 | GO:0072686 | mitotic spindle(GO:0072686) |
0.1 | 0.2 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 0.4 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 0.5 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.1 | 0.3 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 21.4 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.1 | 9.8 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 0.3 | GO:0030662 | coated vesicle membrane(GO:0030662) |
0.1 | 0.4 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.1 | 0.1 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.1 | 1.3 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 1.8 | GO:0010008 | endosome membrane(GO:0010008) |
0.1 | 0.3 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.1 | 0.2 | GO:0043511 | inhibin complex(GO:0043511) |
0.1 | 0.2 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 0.7 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.1 | 7.7 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.1 | 0.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 3.9 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.1 | 2.8 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.1 | 0.6 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 1.4 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.1 | 0.2 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.1 | 0.5 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 0.4 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.1 | 0.2 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.1 | 0.7 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.1 | 0.1 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.1 | 52.9 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 0.4 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 0.8 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 1.9 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 0.7 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.1 | 0.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.1 | 1.8 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 0.2 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.1 | 0.1 | GO:0031983 | vesicle lumen(GO:0031983) |
0.1 | 0.1 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.1 | 0.2 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 0.8 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.1 | 1.1 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.1 | 0.6 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.1 | 0.4 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 0.2 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 0.1 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 4.8 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 0.3 | GO:0097546 | ciliary base(GO:0097546) |
0.1 | 0.2 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 1.7 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.1 | 0.5 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.1 | 1.0 | GO:0090544 | BAF-type complex(GO:0090544) |
0.1 | 0.2 | GO:0000938 | GARP complex(GO:0000938) |
0.1 | 0.2 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.1 | 0.2 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 0.9 | GO:0005844 | polysome(GO:0005844) |
0.1 | 0.1 | GO:0032584 | growth cone membrane(GO:0032584) |
0.1 | 0.3 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 0.3 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 0.2 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.0 | 0.2 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.0 | 1.6 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 0.1 | GO:0044327 | dendritic spine head(GO:0044327) |
0.0 | 0.1 | GO:0001520 | outer dense fiber(GO:0001520) |
0.0 | 0.3 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.0 | 0.1 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.0 | 1.8 | GO:0005923 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.0 | 3.5 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 0.2 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.0 | 45.9 | GO:0005654 | nucleoplasm(GO:0005654) |
0.0 | 1.0 | GO:0000922 | spindle pole(GO:0000922) |
0.0 | 0.1 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.0 | 0.1 | GO:0072687 | meiotic spindle(GO:0072687) |
0.0 | 0.2 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.0 | 1.2 | GO:0030496 | midbody(GO:0030496) |
0.0 | 3.1 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 0.4 | GO:0031528 | microvillus membrane(GO:0031528) |
0.0 | 0.6 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.0 | GO:0097441 | basilar dendrite(GO:0097441) |
0.0 | 0.3 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.0 | 0.0 | GO:0042827 | platelet dense granule(GO:0042827) |
0.0 | 3.1 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.2 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.0 | 0.2 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.0 | 28.0 | GO:0005829 | cytosol(GO:0005829) |
0.0 | 1.2 | GO:0005903 | brush border(GO:0005903) |
0.0 | 5.1 | GO:0005813 | centrosome(GO:0005813) |
0.0 | 2.4 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 0.3 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.0 | 0.1 | GO:0042627 | chylomicron(GO:0042627) |
0.0 | 0.6 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.0 | 0.1 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 0.3 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.0 | 0.2 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.0 | 0.0 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.0 | 0.1 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.0 | 0.0 | GO:0097255 | R2TP complex(GO:0097255) |
0.0 | 3.3 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 2.0 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 0.3 | GO:0036126 | sperm flagellum(GO:0036126) |
0.0 | 0.0 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.0 | 1.3 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.3 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 0.7 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.0 | 0.2 | GO:0014704 | intercalated disc(GO:0014704) |
0.0 | 5.7 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.1 | GO:0005883 | neurofilament(GO:0005883) |
0.0 | 20.4 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 0.1 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.0 | 0.2 | GO:0005694 | chromosome(GO:0005694) |
0.0 | 2.1 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 0.1 | GO:0030118 | clathrin coat(GO:0030118) |
0.0 | 0.0 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 0.1 | GO:0043296 | apical junction complex(GO:0043296) |
0.0 | 0.0 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.0 | 0.1 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.0 | 0.1 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 0.2 | GO:0016011 | dystroglycan complex(GO:0016011) |
0.0 | 0.1 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.0 | 0.2 | GO:0008305 | integrin complex(GO:0008305) |
0.0 | 0.1 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.0 | 0.0 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.1 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.0 | 0.1 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.1 | GO:0032009 | early phagosome(GO:0032009) |
0.0 | 0.6 | GO:0043197 | dendritic spine(GO:0043197) |
0.0 | 0.9 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.3 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.0 | 0.1 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.0 | 0.4 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.1 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.0 | 0.0 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.0 | 0.0 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.0 | 3.5 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.0 | 0.0 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.0 | 0.0 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.0 | 0.4 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 0.0 | GO:0031248 | protein acetyltransferase complex(GO:0031248) acetyltransferase complex(GO:1902493) |
0.0 | 0.0 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.0 | 54.7 | GO:0005634 | nucleus(GO:0005634) |
0.0 | 0.0 | GO:0035838 | growing cell tip(GO:0035838) |
0.0 | 0.0 | GO:0072534 | perineuronal net(GO:0072534) |
0.0 | 0.3 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.0 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.0 | 0.0 | GO:0016234 | inclusion body(GO:0016234) |
0.0 | 0.3 | GO:0031514 | motile cilium(GO:0031514) |
0.0 | 0.0 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.1 | GO:0097440 | apical dendrite(GO:0097440) |
0.0 | 0.0 | GO:0044292 | dendrite terminus(GO:0044292) |
0.0 | 0.1 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 0.2 | GO:0043205 | fibril(GO:0043205) |
0.0 | 0.0 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.0 | 0.3 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.0 | 0.3 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.0 | 0.3 | GO:0043292 | contractile fiber(GO:0043292) |
0.0 | 0.0 | GO:0031231 | intrinsic component of peroxisomal membrane(GO:0031231) |
0.0 | 0.0 | GO:0036128 | CatSper complex(GO:0036128) |
0.0 | 0.0 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.1 | 6.2 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
1.8 | 7.1 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
1.5 | 4.5 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
1.5 | 6.0 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
1.3 | 3.8 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
1.1 | 3.4 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
1.0 | 5.1 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
1.0 | 4.0 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
1.0 | 2.9 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.9 | 3.8 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.8 | 8.3 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.7 | 2.2 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.7 | 2.9 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.7 | 2.9 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.7 | 2.7 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.7 | 3.3 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.6 | 3.2 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.6 | 5.2 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.6 | 3.4 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.6 | 1.7 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.6 | 1.7 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.6 | 1.7 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.6 | 2.8 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.5 | 2.7 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.5 | 1.5 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.5 | 1.5 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.5 | 1.5 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.5 | 1.4 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.5 | 8.6 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.5 | 3.8 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.5 | 1.4 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.5 | 2.7 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.4 | 2.6 | GO:0030274 | LIM domain binding(GO:0030274) |
0.4 | 2.1 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.4 | 1.7 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.4 | 1.2 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.4 | 1.2 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.4 | 1.2 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.4 | 3.6 | GO:0070513 | death domain binding(GO:0070513) |
0.4 | 0.8 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.4 | 1.2 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.4 | 0.4 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.4 | 1.1 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.4 | 2.6 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.4 | 1.1 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.4 | 1.1 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.4 | 1.5 | GO:0042731 | PH domain binding(GO:0042731) |
0.4 | 1.1 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.3 | 1.0 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.3 | 1.4 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.3 | 2.4 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.3 | 1.0 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.3 | 2.4 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.3 | 2.3 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.3 | 2.0 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.3 | 2.3 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.3 | 1.0 | GO:0050692 | DBD domain binding(GO:0050692) |
0.3 | 1.0 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.3 | 1.0 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.3 | 1.0 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.3 | 1.3 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.3 | 0.9 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.3 | 12.9 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.3 | 1.8 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.3 | 2.7 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.3 | 0.9 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.3 | 2.1 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.3 | 1.4 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.3 | 0.9 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.3 | 0.9 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.3 | 0.8 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.3 | 0.3 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.3 | 1.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.3 | 1.1 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.3 | 1.3 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.3 | 0.8 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.3 | 3.4 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.3 | 0.8 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.3 | 3.9 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.3 | 0.8 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.3 | 1.0 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.3 | 0.8 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.3 | 1.0 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.2 | 0.7 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.2 | 0.7 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.2 | 0.7 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.2 | 1.7 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.2 | 1.2 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.2 | 1.2 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.2 | 1.2 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.2 | 0.7 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.2 | 0.7 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.2 | 1.9 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.2 | 2.1 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.2 | 0.7 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.2 | 0.9 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.2 | 3.0 | GO:0031005 | filamin binding(GO:0031005) |
0.2 | 0.2 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
0.2 | 2.1 | GO:0035173 | histone kinase activity(GO:0035173) |
0.2 | 2.0 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.2 | 1.1 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.2 | 0.7 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.2 | 0.2 | GO:0080084 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.2 | 3.3 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.2 | 0.7 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.2 | 1.1 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.2 | 2.6 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.2 | 1.9 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.2 | 2.0 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.2 | 1.2 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.2 | 0.8 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.2 | 0.6 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.2 | 1.6 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.2 | 0.6 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.2 | 1.2 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.2 | 0.8 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.2 | 0.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 1.2 | GO:0015288 | porin activity(GO:0015288) |
0.2 | 1.5 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.2 | 1.9 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.2 | 2.1 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.2 | 0.2 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.2 | 1.5 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.2 | 0.6 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.2 | 0.6 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.2 | 0.4 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.2 | 0.2 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.2 | 9.0 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.2 | 0.5 | GO:0019961 | interferon binding(GO:0019961) |
0.2 | 1.4 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.2 | 1.6 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.2 | 0.3 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.2 | 0.7 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.2 | 3.6 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.2 | 1.3 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.2 | 0.3 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.2 | 1.1 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.2 | 2.8 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.2 | 1.3 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.2 | 0.5 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.2 | 0.6 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.2 | 0.8 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.2 | 0.2 | GO:0030523 | dihydrolipoamide S-acyltransferase activity(GO:0030523) |
0.2 | 2.2 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.2 | 0.8 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.2 | 1.6 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.2 | 0.8 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.2 | 1.1 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.2 | 0.6 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.2 | 0.6 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.2 | 0.5 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.2 | 2.9 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.2 | 0.9 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.2 | 4.7 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.2 | 1.1 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.2 | 6.3 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
0.2 | 0.8 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.2 | 0.5 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.1 | 0.7 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.1 | 4.5 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.7 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.1 | 0.9 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 0.4 | GO:0004103 | choline kinase activity(GO:0004103) |
0.1 | 2.9 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 0.1 | GO:0045118 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.1 | 0.1 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.1 | 0.6 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.1 | 0.1 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) tRNA guanylyltransferase activity(GO:0008193) |
0.1 | 0.4 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.1 | 4.0 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.3 | GO:0051734 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.1 | 1.1 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 0.7 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.1 | 1.0 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 5.0 | GO:0005504 | fatty acid binding(GO:0005504) |
0.1 | 2.0 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.4 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.1 | 1.0 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.1 | 0.6 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.1 | 0.4 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.1 | 0.4 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.1 | 0.7 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.1 | 3.3 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 1.1 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.1 | 0.4 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.1 | 1.2 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 0.4 | GO:0051425 | PTB domain binding(GO:0051425) |
0.1 | 6.6 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 1.5 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.1 | 0.4 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.1 | 0.9 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.1 | 1.8 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 2.0 | GO:0008143 | poly(A) binding(GO:0008143) |
0.1 | 0.3 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.1 | 0.3 | GO:0030172 | troponin C binding(GO:0030172) |
0.1 | 0.4 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.1 | 2.6 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 0.5 | GO:0052795 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 0.9 | GO:0018630 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.1 | 0.8 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.1 | 3.1 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 1.1 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.1 | 3.5 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 1.6 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.1 | 2.3 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 0.4 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.1 | 0.5 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.1 | 1.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.1 | 4.1 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.1 | 0.5 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 0.4 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 0.2 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.1 | 0.7 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.1 | 0.5 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.1 | 0.8 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.1 | 0.4 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.1 | 0.6 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 0.4 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.1 | 4.1 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 2.1 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.9 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.1 | 0.6 | GO:0034046 | poly(G) binding(GO:0034046) |
0.1 | 0.6 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 0.6 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
0.1 | 0.2 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.1 | 0.2 | GO:0005350 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.1 | 22.6 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 1.2 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 0.4 | GO:0009374 | biotin binding(GO:0009374) |
0.1 | 0.4 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.1 | 0.9 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 2.5 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.1 | 1.1 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 0.8 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.1 | GO:0070061 | fructose binding(GO:0070061) |
0.1 | 0.9 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.1 | 1.1 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 0.7 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 0.4 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.1 | 0.5 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 0.3 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.1 | 3.6 | GO:0051723 | protein methylesterase activity(GO:0051723) |
0.1 | 0.5 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 0.5 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.1 | 0.5 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 0.4 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.1 | 1.1 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 0.9 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 0.6 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 0.5 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.1 | 0.5 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.1 | 4.3 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 9.1 | GO:0008026 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.1 | 0.4 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 0.3 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.1 | 0.3 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.1 | 0.5 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.1 | 0.3 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 0.1 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.1 | 0.3 | GO:0030984 | kininogen binding(GO:0030984) |
0.1 | 0.5 | GO:1990405 | protein antigen binding(GO:1990405) |
0.1 | 0.3 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.1 | 1.0 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.1 | 0.8 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 0.3 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.1 | 0.4 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.1 | 0.5 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.1 | 0.6 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 0.3 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.1 | 0.4 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 0.5 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.3 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.1 | 0.6 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 0.4 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.1 | 0.4 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 0.3 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.1 | 0.4 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.1 | 2.2 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 0.3 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.1 | 0.4 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 0.4 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 2.1 | GO:0000049 | tRNA binding(GO:0000049) |
0.1 | 0.4 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 0.1 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.1 | 0.3 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 0.1 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.1 | 0.2 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 16.7 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.5 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 0.3 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 0.3 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.1 | 0.3 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.1 | 0.1 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.1 | 0.1 | GO:0032451 | demethylase activity(GO:0032451) |
0.1 | 0.7 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.1 | 0.3 | GO:0004359 | glutaminase activity(GO:0004359) |
0.1 | 1.0 | GO:0019841 | retinol binding(GO:0019841) |
0.1 | 0.1 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.1 | 0.4 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 0.5 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 0.5 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 2.1 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 0.1 | GO:0033592 | RNA strand annealing activity(GO:0033592) annealing activity(GO:0097617) |
0.1 | 1.0 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.1 | 0.2 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.1 | 0.2 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.1 | 0.9 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.1 | 0.9 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) sulfate transmembrane transporter activity(GO:0015116) |
0.1 | 0.2 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.1 | 0.2 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.1 | 0.2 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.1 | 0.6 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 0.6 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.1 | 0.9 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 1.1 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.1 | 0.2 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 1.1 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 2.5 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.1 | 0.1 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.1 | 0.8 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 0.5 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.1 | 0.6 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.2 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.1 | 0.3 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.1 | 3.6 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.1 | 0.7 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.1 | 0.2 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 0.1 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.1 | 0.4 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 0.3 | GO:0015266 | protein channel activity(GO:0015266) |
0.1 | 0.1 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.9 | GO:0005542 | folic acid binding(GO:0005542) |
0.1 | 0.3 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.1 | 0.4 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.1 | 0.3 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.1 | 0.8 | GO:0019843 | rRNA binding(GO:0019843) |
0.1 | 2.3 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.1 | 0.5 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.1 | 0.2 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.1 | 4.9 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
0.1 | 0.2 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.7 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 1.5 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 0.3 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.1 | 0.3 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.1 | 0.1 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.1 | 3.6 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 0.2 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.1 | 8.3 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.9 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.1 | 0.2 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.1 | 0.1 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.1 | 0.8 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 0.3 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 1.9 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.1 | 0.4 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.1 | 0.2 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 0.1 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.1 | 0.4 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 0.1 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) |
0.1 | 0.1 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.1 | 0.5 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 0.3 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 0.2 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 0.1 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.1 | 5.2 | GO:0035326 | enhancer binding(GO:0035326) |
0.1 | 0.2 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.1 | 0.5 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 0.3 | GO:0016421 | CoA carboxylase activity(GO:0016421) ligase activity, forming carbon-carbon bonds(GO:0016885) |
0.1 | 0.1 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.1 | 1.6 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.1 | 0.3 | GO:0030371 | translation repressor activity(GO:0030371) |
0.1 | 0.5 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 0.1 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.1 | 0.4 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 1.3 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.1 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.1 | 1.0 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.1 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 0.4 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 0.7 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 0.1 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.1 | 0.8 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 0.1 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 2.4 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.1 | 0.3 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.1 | 0.8 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 0.1 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.1 | 0.4 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.1 | 0.1 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.1 | 1.3 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 3.0 | GO:0051087 | chaperone binding(GO:0051087) |
0.1 | 0.1 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.1 | 0.4 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.1 | 0.8 | GO:0032183 | SUMO binding(GO:0032183) |
0.1 | 0.1 | GO:0004096 | catalase activity(GO:0004096) |
0.1 | 0.4 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 0.2 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.1 | 0.2 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.1 | 2.7 | GO:0000149 | SNARE binding(GO:0000149) |
0.1 | 0.6 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.1 | 0.3 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 1.0 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 18.1 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.1 | 0.2 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.1 | 0.3 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.2 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 0.2 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.1 | 0.1 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.1 | 1.9 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 0.3 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.1 | 0.4 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.1 | 0.4 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.1 | 0.2 | GO:0000339 | RNA cap binding(GO:0000339) |
0.1 | 0.1 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.1 | 2.3 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 2.8 | GO:0038024 | cargo receptor activity(GO:0038024) |
0.1 | 0.1 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.1 | 0.2 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.1 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.1 | 0.1 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 0.5 | GO:0018450 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.1 | 0.1 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.1 | 0.2 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 0.1 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.1 | 0.8 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.1 | 0.2 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.6 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.1 | 0.6 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.3 | GO:0016248 | channel inhibitor activity(GO:0016248) |
0.1 | 0.1 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 0.2 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.1 | 2.6 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.1 | 0.2 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 0.2 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.1 | 0.9 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.1 | 0.1 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.1 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.1 | 0.9 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 0.2 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 0.1 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.1 | 1.0 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 0.1 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.1 | 2.4 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 0.2 | GO:0030515 | snoRNA binding(GO:0030515) |
0.1 | 1.5 | GO:0004527 | exonuclease activity(GO:0004527) |
0.1 | 2.2 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.1 | 0.3 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.1 | 0.2 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.1 | 0.9 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.1 | 0.3 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.1 | 0.2 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.1 | 0.3 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.1 | 0.3 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.1 | 0.2 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.1 | 0.2 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.1 | 0.1 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.1 | 3.0 | GO:0051020 | GTPase binding(GO:0051020) |
0.1 | 2.4 | GO:0051117 | ATPase binding(GO:0051117) |
0.1 | 0.4 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.1 | 0.2 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.1 | 0.1 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.1 | 0.2 | GO:0000700 | mismatch base pair DNA N-glycosylase activity(GO:0000700) purine-specific mismatch base pair DNA N-glycosylase activity(GO:0000701) single-strand selective uracil DNA N-glycosylase activity(GO:0017065) nicotinamide riboside hydrolase activity(GO:0070635) nicotinic acid riboside hydrolase activity(GO:0070636) deoxyribonucleoside 5'-monophosphate N-glycosidase activity(GO:0070694) |
0.1 | 1.6 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 0.3 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.0 | 0.2 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.0 | 0.4 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 0.2 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 0.2 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.0 | 0.2 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.0 | 0.1 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.0 | 0.1 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.0 | 0.1 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.0 | 1.1 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.0 | 0.0 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.0 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.0 | 2.6 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 0.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.0 | 0.7 | GO:0045502 | dynein binding(GO:0045502) |
0.0 | 0.2 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.0 | 0.5 | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding(GO:0000981) |
0.0 | 0.1 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.0 | 5.0 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.0 | 0.1 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.0 | 1.7 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.1 | GO:0038100 | nodal binding(GO:0038100) |
0.0 | 1.7 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.0 | 0.1 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.0 | 0.1 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.0 | 0.1 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.0 | 0.1 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.0 | 0.2 | GO:0070402 | NADPH binding(GO:0070402) |
0.0 | 0.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.0 | 0.1 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.0 | 0.1 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.0 | 0.4 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.0 | 0.3 | GO:0050733 | RS domain binding(GO:0050733) |
0.0 | 0.0 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.0 | 0.4 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.1 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.0 | 0.3 | GO:0016936 | galactoside binding(GO:0016936) |
0.0 | 0.2 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.0 | 0.1 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.0 | 0.0 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.0 | 0.1 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.0 | 0.0 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.0 | 0.1 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.0 | 0.7 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.0 | 0.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 0.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.1 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.0 | 0.1 | GO:0019002 | GMP binding(GO:0019002) |
0.0 | 0.4 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.3 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.0 | GO:0046921 | alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.0 | 0.1 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.0 | 0.1 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
0.0 | 0.1 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 3.4 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 0.2 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.0 | 0.7 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.2 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.0 | 0.2 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.0 | 0.0 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.0 | 0.9 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.5 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.4 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.0 | 0.1 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.0 | 0.0 | GO:0019862 | IgA binding(GO:0019862) |
0.0 | 0.3 | GO:0043955 | acyl-CoA ligase activity(GO:0003996) 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.0 | 0.1 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.0 | 0.4 | GO:0015368 | calcium:cation antiporter activity(GO:0015368) |
0.0 | 1.2 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.0 | 0.7 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.0 | 0.3 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 0.2 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.0 | 0.2 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 0.2 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.2 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.0 | 0.0 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.7 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.0 | 0.2 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.0 | 0.3 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 0.2 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.0 | 0.8 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.0 | 0.5 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.0 | 2.3 | GO:0001047 | core promoter binding(GO:0001047) |
0.0 | 0.3 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.0 | 0.1 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.0 | 0.2 | GO:0030145 | manganese ion binding(GO:0030145) |
0.0 | 2.0 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.0 | 0.5 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.4 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.1 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.0 | 0.0 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.0 | 0.7 | GO:0017022 | myosin binding(GO:0017022) |
0.0 | 0.2 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.0 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.0 | 0.4 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.4 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.0 | 1.6 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.0 | 0.1 | GO:0018562 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.0 | 1.0 | GO:0035064 | methylated histone binding(GO:0035064) |
0.0 | 1.0 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.0 | 0.1 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.0 | 0.1 | GO:0031491 | nucleosome binding(GO:0031491) |
0.0 | 0.1 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.0 | 0.1 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.0 | 0.0 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.0 | 0.5 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 0.1 | GO:0090079 | translation regulator activity, nucleic acid binding(GO:0090079) |
0.0 | 1.8 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 0.5 | GO:0001848 | complement binding(GO:0001848) |
0.0 | 0.1 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.0 | 0.3 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.0 | 0.2 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.0 | 0.2 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.0 | 0.1 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.0 | 0.0 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.0 | 0.1 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.0 | 0.3 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.0 | 0.6 | GO:0016414 | O-octanoyltransferase activity(GO:0016414) |
0.0 | 0.5 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.0 | 0.4 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.0 | 2.3 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.0 | 0.3 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.0 | 0.0 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.0 | 0.4 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.0 | 0.3 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.1 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.0 | 0.1 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.1 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.0 | 0.1 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.0 | 0.2 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.0 | 0.1 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.0 | 17.7 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.0 | 0.6 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.4 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.0 | 0.8 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.2 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.8 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.0 | 0.0 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.0 | 0.0 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.0 | 0.4 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.0 | 0.6 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.2 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.0 | 2.2 | GO:0004518 | nuclease activity(GO:0004518) |
0.0 | 0.9 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.4 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.1 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.0 | 0.2 | GO:0016725 | oxidoreductase activity, acting on CH or CH2 groups(GO:0016725) oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.0 | 0.6 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.0 | 0.1 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.0 | 0.0 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.0 | 0.1 | GO:0048038 | quinone binding(GO:0048038) |
0.0 | 0.0 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.0 | 0.1 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.0 | 0.8 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.1 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.0 | 0.1 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.0 | GO:0045182 | translation regulator activity(GO:0045182) |
0.0 | 0.6 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.1 | GO:0000182 | rDNA binding(GO:0000182) |
0.0 | 0.5 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.0 | 1.0 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.0 | 0.5 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
0.0 | 0.1 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.0 | 0.0 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.0 | 0.1 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.0 | 0.1 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.0 | 1.3 | GO:0043492 | ATPase activity, coupled to movement of substances(GO:0043492) |
0.0 | 0.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.3 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.0 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.0 | 0.5 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.0 | 0.1 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.0 | 0.1 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.0 | 0.0 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.0 | 0.4 | GO:0050660 | flavin adenine dinucleotide binding(GO:0050660) |
0.0 | 0.1 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.0 | 0.5 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.0 | 0.1 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.0 | 0.1 | GO:0031014 | troponin T binding(GO:0031014) |
0.0 | 0.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.0 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.0 | 0.0 | GO:0051536 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
0.0 | 0.1 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 0.1 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.0 | 0.1 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.0 | 0.0 | GO:0015232 | heme transporter activity(GO:0015232) |
0.0 | 0.0 | GO:0034452 | dynactin binding(GO:0034452) |
0.0 | 0.1 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.0 | 0.1 | GO:0016229 | steroid dehydrogenase activity(GO:0016229) |
0.0 | 0.0 | GO:0034618 | arginine binding(GO:0034618) |
0.0 | 0.2 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.0 | 0.1 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.0 | 0.0 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.0 | 0.1 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.0 | 0.6 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.0 | 0.1 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.0 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.0 | 0.0 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.0 | 0.8 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.1 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.0 | 0.0 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.0 | 1.6 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.0 | 0.3 | GO:0008483 | transaminase activity(GO:0008483) |
0.0 | 0.1 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.0 | 0.1 | GO:0051431 | corticotropin-releasing hormone receptor binding(GO:0051429) corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.0 | 0.4 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.0 | 0.2 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.0 | 0.1 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.0 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.0 | 0.6 | GO:0016773 | phosphotransferase activity, alcohol group as acceptor(GO:0016773) |
0.0 | 0.0 | GO:0052872 | tocotrienol omega-hydroxylase activity(GO:0052872) |
0.0 | 0.0 | GO:0043199 | sulfate binding(GO:0043199) |
0.0 | 0.0 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.1 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.0 | 0.0 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.0 | 0.1 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.0 | 1.4 | GO:0004857 | enzyme inhibitor activity(GO:0004857) |
0.0 | 0.2 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.0 | 0.2 | GO:0005310 | dicarboxylic acid transmembrane transporter activity(GO:0005310) |
0.0 | 0.2 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.0 | 0.4 | GO:0015179 | L-amino acid transmembrane transporter activity(GO:0015179) |
0.0 | 1.8 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.1 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.1 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 0.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.0 | 0.6 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.0 | 0.1 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.0 | 0.3 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.0 | GO:0030351 | inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity(GO:0030351) inositol-1,4,5,6-tetrakisphosphate 6-phosphatase activity(GO:0030352) inositol pentakisphosphate phosphatase activity(GO:0052827) |
0.0 | 0.0 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.0 | 0.0 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.0 | 0.0 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.0 | 0.0 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.1 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.0 | 0.1 | GO:0044548 | S100 protein binding(GO:0044548) |
0.0 | 0.0 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.0 | 0.4 | GO:0060090 | binding, bridging(GO:0060090) |
0.0 | 0.1 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.2 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 0.1 | GO:0034416 | bisphosphoglycerate mutase activity(GO:0004082) bisphosphoglycerate 2-phosphatase activity(GO:0004083) phosphoglycerate mutase activity(GO:0004619) bisphosphoglycerate phosphatase activity(GO:0034416) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.0 | 0.1 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 0.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 0.1 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 2.8 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.1 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.0 | 0.0 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.0 | 0.1 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.0 | 0.0 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.0 | 0.0 | GO:0005372 | water transmembrane transporter activity(GO:0005372) |
0.0 | 0.0 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 0.0 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.0 | GO:0016415 | octanoyltransferase activity(GO:0016415) |
0.0 | 0.2 | GO:0052635 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) hypophosphite dioxygenase activity(GO:0034792) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
0.0 | 6.9 | GO:0001882 | nucleoside binding(GO:0001882) |
0.0 | 0.0 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.0 | 0.0 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.0 | 13.3 | GO:0003677 | DNA binding(GO:0003677) |
0.0 | 0.1 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 0.1 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.0 | 0.0 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.0 | 0.0 | GO:0000009 | alpha-1,6-mannosyltransferase activity(GO:0000009) |
0.0 | 0.1 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.0 | 0.1 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.0 | 15.9 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 2.2 | GO:0017171 | serine hydrolase activity(GO:0017171) |
0.0 | 0.0 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.3 | GO:0008392 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.0 | 0.0 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.0 | 0.1 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.0 | 0.2 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.1 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.0 | 0.0 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.0 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.0 | 0.1 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.0 | 0.0 | GO:0015149 | hexose transmembrane transporter activity(GO:0015149) |
0.0 | 0.0 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.0 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.0 | 0.0 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.0 | 0.0 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.0 | 0.0 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.0 | 0.9 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.0 | 0.0 | GO:0008142 | oxysterol binding(GO:0008142) |
0.0 | 0.1 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.0 | 0.0 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.0 | 0.6 | GO:0008134 | transcription factor binding(GO:0008134) |
0.0 | 0.1 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.0 | 0.1 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.0 | 0.0 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.0 | 0.0 | GO:0051373 | FATZ binding(GO:0051373) |
0.0 | 0.0 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 0.2 | GO:0046915 | transition metal ion transmembrane transporter activity(GO:0046915) |
0.0 | 0.0 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.0 | 0.4 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.0 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.0 | 0.2 | GO:0003823 | antigen binding(GO:0003823) |
0.0 | 0.1 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 5.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.3 | 2.6 | ST STAT3 PATHWAY | STAT3 Pathway |
0.3 | 3.7 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.3 | 4.0 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.3 | 6.3 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.2 | 0.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.2 | 7.1 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.2 | 4.4 | PID MYC PATHWAY | C-MYC pathway |
0.2 | 2.1 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.2 | 3.1 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.2 | 8.7 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.2 | 4.0 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.2 | 4.9 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.2 | 2.8 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.2 | 1.1 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.2 | 2.7 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.2 | 2.3 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.2 | 4.1 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.2 | 3.9 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.2 | 0.2 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.2 | 5.8 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.2 | 5.5 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.2 | 6.3 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.2 | 3.3 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 0.3 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.1 | 4.7 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 0.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 4.6 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.1 | 2.0 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 4.6 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 1.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 1.6 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 3.2 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 0.9 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 2.9 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 4.2 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 1.4 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 0.5 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 2.6 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 0.7 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.1 | 1.4 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 4.1 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 3.1 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 2.8 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 0.3 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 0.2 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 1.5 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 1.9 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 3.6 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 2.0 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 1.5 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 2.7 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 1.8 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 0.9 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 1.2 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.1 | 0.9 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 1.1 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 2.6 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 0.7 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 1.2 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 0.1 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.1 | 0.5 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.1 | 0.9 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 0.1 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 0.9 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 2.2 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 2.4 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 1.5 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 0.5 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 0.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 0.3 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 0.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 0.5 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 1.2 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 0.6 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 0.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 0.2 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 0.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 0.5 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 0.6 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 0.6 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.6 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.1 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.3 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 2.3 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.4 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.5 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.7 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.6 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.3 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.5 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.7 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.4 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.1 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.0 | 0.9 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 0.3 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.2 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 0.4 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.5 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.1 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.3 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 0.4 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 0.4 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 0.0 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 0.1 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.3 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.6 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.1 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 0.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 0.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.1 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.0 | 0.4 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 0.0 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.0 | 0.0 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.2 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.1 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.4 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.1 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.0 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.2 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.0 | 0.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.1 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.0 | 0.1 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.3 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.1 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 0.0 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.0 | 1.7 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.3 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 0.0 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.0 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.0 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.1 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 0.1 | PID ALK1 PATHWAY | ALK1 signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 0.9 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.7 | 7.9 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.5 | 5.3 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.5 | 2.0 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.5 | 3.9 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.4 | 5.7 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.4 | 4.3 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.3 | 4.0 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.3 | 0.3 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.3 | 7.8 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.3 | 2.9 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.3 | 1.7 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.3 | 2.6 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.3 | 2.6 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.2 | 1.0 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.2 | 3.3 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.2 | 3.7 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.2 | 2.8 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.2 | 0.2 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.2 | 5.4 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.2 | 2.6 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.2 | 2.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.2 | 3.2 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.2 | 5.4 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.2 | 4.4 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.2 | 0.2 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.2 | 2.2 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.2 | 1.7 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.2 | 2.9 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.2 | 0.4 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.2 | 2.4 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.2 | 6.6 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.2 | 2.8 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.2 | 2.9 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.2 | 0.6 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.2 | 0.2 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.2 | 1.0 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.2 | 1.1 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.2 | 2.1 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.2 | 1.1 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.2 | 2.2 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
0.2 | 3.1 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.2 | 1.5 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 4.5 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.1 | 2.1 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.1 | 0.6 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.1 | 1.9 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 1.6 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.1 | 0.3 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 1.4 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.1 | 1.8 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 2.5 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 1.8 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 3.3 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 2.2 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 1.5 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.1 | 3.3 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.1 | 1.8 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 0.4 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.1 | 7.2 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.1 | 2.4 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.1 | 6.0 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 3.5 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.1 | 1.7 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 1.9 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 0.4 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.1 | 3.8 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 1.1 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.1 | 1.0 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 0.2 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.1 | 1.3 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 1.8 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 0.5 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 0.7 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 4.8 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 1.2 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.1 | 8.6 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.1 | 0.7 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 0.7 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 6.8 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 2.9 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 1.7 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.1 | 8.1 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 0.8 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 0.4 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.1 | 2.9 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.1 | 0.5 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 4.4 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 1.3 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.1 | 1.0 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 6.6 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 2.9 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 2.3 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 0.4 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 0.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.1 | 0.3 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.1 | 1.0 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.1 | 0.8 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.1 | 0.9 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.1 | 3.3 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.1 | 1.2 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 1.1 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 1.2 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 0.5 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 0.1 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.1 | 2.2 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.1 | 0.4 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 1.1 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.1 | 0.2 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.1 | 0.6 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.1 | 1.1 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.1 | 1.0 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.1 | 0.4 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 1.5 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 1.5 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 2.2 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 1.1 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 0.4 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 1.5 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 2.2 | REACTOME TRANSLATION | Genes involved in Translation |
0.1 | 1.2 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.1 | 0.8 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.1 | 0.7 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 1.1 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 0.6 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 1.0 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 0.4 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 0.7 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
0.1 | 0.6 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 0.4 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 0.6 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 0.8 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 0.9 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.1 | 2.7 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 1.3 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 1.4 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 0.8 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 0.4 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 0.2 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.1 | 0.6 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 0.4 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 0.5 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 2.4 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.1 | 0.2 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.1 | 0.5 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.1 | 0.7 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 0.4 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 0.3 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.1 | 0.2 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 2.2 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 0.4 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 1.1 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 0.3 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.1 | 0.6 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 0.3 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 0.3 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 0.9 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.1 | 0.7 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 1.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.3 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.0 | 0.1 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.1 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 0.5 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 0.3 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 6.6 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.4 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.0 | 0.0 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.1 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.0 | 0.0 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 1.2 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 0.1 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.0 | 0.2 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.3 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 4.4 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 0.2 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 0.2 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.2 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.0 | 0.5 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.0 | 0.4 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 0.0 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.0 | 2.2 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.0 | 1.7 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.0 | 0.4 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 0.1 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.0 | 2.7 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.3 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 0.3 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.0 | 0.3 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.0 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.0 | 0.7 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.0 | 0.6 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.3 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.0 | 0.7 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.0 | 0.2 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.2 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.3 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.2 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.0 | 0.2 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
0.0 | 0.3 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.2 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 0.4 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.0 | 0.0 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.2 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.1 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.0 | 0.1 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 0.2 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.4 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.0 | 0.1 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 0.1 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 0.0 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.0 | 0.5 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 0.2 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.0 | 0.4 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 0.1 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.0 | 0.0 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.0 | 0.1 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.0 | 0.1 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.3 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.2 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.3 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.0 | 0.2 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.0 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 0.2 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.2 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.0 | 0.0 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 0.0 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.0 | 0.2 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.0 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 0.0 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.0 | 0.1 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.0 | 0.1 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.1 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.0 | 0.2 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.0 | 0.0 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.0 | 0.3 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.0 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.0 | 0.0 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.0 | 0.3 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.1 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.0 | 0.0 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 0.0 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |